在安德森內搜尋:
Search this site
106 results found with an empty search
- Delayed Reconstruction | 安德森整形外科診所
Primary Lymphedema 淋巴管靜脈吻合術:安德森的專業技術, 您的安心選擇及案例分享 Delayed Reconstruction Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery Treatment Instructions Delayed breast reconstruction refers to a situation where breast cancer patients do not choose to undergo breast reconstruction at the time of mastectomy, or they miss the opportunity for immediate reconstruction due to a lack of information. Some patients may temporarily decline reconstruction surgery due to fear of cancer, concerns about the success rate of the surgery, or other reasons. After completing breast cancer treatment, including chemotherapy and/or radiation therapy, they undergo breast reconstruction at a later time. This second surgery is known as delayed breast reconstruction. Regain beauty and confidence. DIEP Flap (1) DIEP Flap (2) Anderson, Your safe choice Medical Center Specifications and Equipment The operating room is equipped with Mitaka microscopes, of which there are only four in Taiwan. They have a resolution of up to 16 million pixels and can magnify 42 times optically. They are very suitable for the anastomosis of lymphatic vessels and veins of 0.5 mm and are often used in lymphatic venous anastomosis, such as preoperative evaluation and intraoperative evaluation of the permeability of sutures, making the operation more stable and safe. Is delayed reconstruction more difficult? Delayed breast reconstruction is slightly more challenging compared to immediate breast reconstruction. Factors such as insufficient skin, scar tissue from previous surgery, and underarm depressions after lymph node clearance are additional considerations. First, during a total mastectomy, if immediate reconstruction is not planned, the breast surgeon will remove excess skin and close the wound with a straight line. Therefore, in autologous tissue breast reconstruction, not only is fat from areas like the abdomen, back, buttocks, or thighs important, but the skin covering the area is also crucial. If the patient opts for implant reconstruction or desires scar placement similar to immediate reconstruction (limited to a smaller area), an additional step is required: inserting a tissue expander to stretch the skin. The second challenge is the scar tissue adhesions or fibrosis within the entire chest area. During the reconstruction surgery, the surgeon must carefully release these scars to create a well-shaped breast. The third issue is the noticeable depression in the underarm, caused by the removal of most lymph nodes. If this depression can be filled during reconstruction, the result will be much more satisfying, particularly improving clothing options and comfort, especially in summer. Another technical challenge arises with free flap breast reconstruction. The surgeon must find a healthy set of blood vessels in the chest to supply blood to the flap. In delayed reconstruction, the thoracodorsal artery may sometimes be unusable due to damage from the first surgery or because severe scarring makes dissection difficult. However, this issue is not the most difficult for experienced surgeons. Most skilled and up-to-date surgeons now use the internal mammary vessels for anastomosis. Although the internal mammary technique is more complex than using the thoracodorsal artery and less experienced surgeons may be hesitant to use it, it yields better results. The fat in the flap survives well due to the abundant blood supply. While delayed reconstruction presents certain challenges, these can be overcome by experienced surgeons. Delayed breast reconstruction can still achieve a natural and beautiful result, making it a highly recommended procedure. Breast cancer survival rates have significantly improved, and we sincerely believe that patients should not have to endure ongoing inconvenience or lifelong feelings of loss and regret due to the absence of a breast. When can delayed reconstruction be done? According to research from the world’s leading cancer hospitals, it is now widely accepted that breast reconstruction can be performed at the same time as mastectomy without increasing the risk of breast cancer recurrence or interfering with the detection of any potential recurrence. As a result, this is not just a trend but the reason why every breast cancer patient, once diagnosed, is immediately referred to a plastic surgeon to discuss reconstruction options. Therefore, the best time for breast reconstruction is whenever the patient expresses a desire to undergo the procedure. In the past, doctors used to advise patients not to undergo reconstruction within two years of a mastectomy, as most breast cancer recurrences happen within this period. However, in recent years, this restriction has been lifted. In Taiwan, particularly at Chang Gung Memorial Hospital, the recurrence rate is 4-5%, while in the U.S. it is 2-3%. Considering the 4-5% recurrence rate versus the 95% of patients whose quality of life and psychological well-being can be improved, such advice now seems unreasonable and unfair. Helping patients feel truly free from breast cancer as soon as possible is the greatest mission and source of fulfillment for reconstructive surgeons. The current consensus is that if chemotherapy or radiation therapy is required after mastectomy, breast reconstruction can be done once these treatments are completed. It is generally recommended to wait about one month after chemotherapy and 3 to 6 months after radiation therapy before proceeding with breast reconstruction surgery. What methods can be used for delayed breast reconstruction? The first method we need to mention is using implants, which can be saline or silicone gel implants. As previously mentioned, in delayed breast reconstruction, there is typically insufficient skin on the chest. Therefore, if implants are used for reconstruction, a tissue expander will be needed as a transitional phase. As the name suggests, a tissue expander is used to stretch the skin or tissue. It requires an initial surgery to place the expander under the skin. Typically, the skin is expanded to be slightly larger than the other breast. After about three months, once the skin has stabilized, a second surgery is performed to remove the expander and replace it with a permanent implant. The second method involves using local autologous tissue or performing breast reconstruction surgery with a free flap. The most suitable methods for breast reconstruction after radiation therapy. If a patient has received radiation therapy, it is not recommended to use only tissue expanders and implants for reconstruction. This is because radiation therapy can cause fibrosis of the skin on the chest, which not only increases the risk of capsular contracture leading to a poor aesthetic outcome but also makes the skin more susceptible to poor wound healing and exposure of the implant. If autologous tissue is insufficient and the patient must choose implant reconstruction, it is recommended that the patient select a latissimus dorsi flap combined with an implant for reconstruction to achieve a result that is both aesthetically pleasing and safe. Transitional period before breast reconstruction: How to buy and choose a breast prosthesis bra? After undergoing a mastectomy, especially for patients who will have delayed breast reconstruction, there will be a period when they cannot wear regular bras. To consider physical balance and appearance when dressing, it is likely necessary to wear a specially designed prosthesis bra. Since a prosthesis is an "external object," even though current technology has improved its quality, it still tends to be heavy and may not fit snugly against the body, making it difficult to balance the weight on one side. Therefore, this is not a long-term solution, and it is advisable for patients to discuss the timing of breast reconstruction with their doctor to address the fundamental issue. The options for purchasing a prosthesis bra are not widespread, as they are produced by specialized manufacturers, some of which offer custom-fitting prosthesis pads and replacement services. Patients can seek professional information and recommendations on selection from their breast surgeon or plastic reconstructive surgeon and nurses. Considerations for Choosing Styles: Style Selection: Avoid styles that may rub against the surgical wounds (e.g., if lymph node clearance was performed under the arm, the opening in the bra under the arm should be slightly lower). Deep Pocket for Padding: The inner pocket for the prosthesis should be deep enough to prevent the padding from sliding out during movement. Wide Shoulder Straps and Supportive Band: This design can help reduce the burden on the shoulders. Higher Coverage at the Front: This helps prevent the prosthesis from slipping out and becoming exposed. Back Closure Design: Avoid frequent friction and pressure on the scar, which can cause pain and tissue hypertrophy. Good Fabric Elasticity: The material should be stretchy enough to conform to the body’s curves. Contact Dr. Cheng For A Consultation If you have Breast Cancer Related Lymphedema and would like to know more about the most advanced treatments, contact Dr. Cheng. Internationally recognized as a leading lymphedema specialist, Dr. Cheng can discuss treatment options, based on your individual case. Dr. Cheng is a member of the American Society of Reconstructive Microsurgery and has performed numerous VLN surgeries on breast cancer survivors and other lymphedema patients. Learn more
- 台灣乳房重建協會 | 安德森整形外科診所
Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery 1 DR. CHENG News 2 PROCEDURES WSLS 2024 3 CENTER Videos 4 GALLERY 5 PATIENT INFORMATION 6 GALLERY 協會介紹 活動花絮 會刊園地 愛心捐款 輔助基金專區 獲得補助款姊妹心得分享 乳房到底是屬於誰的? 乳房是屬於父母的、丈夫的、孩子的,還是女性自己的? 林口長庚紀念醫院乳房重建中心從2000年至2018年12月,已完成超過1500例乳房重建,手術成功率98%,是目前台灣陣容最堅強的乳房重建團隊。協助失去乳房的女性,找回自信,以「深下腹動脈穿通枝皮瓣」乳房重建,不犧牲橫腹直肌,此手術技術及經驗領先,為亞洲第一。
- Upper Extremity Lymphedema | 安德森整形外科診所
瞭解更多手臂淋巴水腫的成因及症狀,以及為何安德森整形外科是您的安心選擇,有任何問題歡迎電話及線上諮詢。 Upper Extremity Lymphedema Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery What Is Upper Extremity Lymphedema? Breast cancer patients who underwent axillary lymph node dissection following radiotherapy are at a higher risk of developing extremity lymphedema – Breast Cancer-Related Lymphedema (BCRL), a condition that results in tissue swelling and liquid retention in the arms. While it is possible to manage the condition with some home care, surgery may be necessary to significantly improve an individual’s comfort and quality of life. Ming-Heui Cheng, MD, FACS, a pioneer in plastic microsurgery and internationally renowned lymphedema specialist, performs vascularized lymph node flap transfers on lymphedema patients whose symptoms have not improved or continue to worsen six months after they emerged. Symptoms Of Lymphedema Of The Arm The affected limb may develop inflammation, infection, adipogenesis, and fibrosis of the tissue. The protein-concentrated fluid that accumulates inside the interstitial tissue may further block or make the drainage of the lymph fluid less efficient or even create an obstruction. Lymphedema of upper extremity causes pain, heaviness, skin hyperkeratosis, fibrosis, discomfort when wearing certain clothes and jewelry, cosmetic problems and limitation of daily activities for patients. It is common for lymphedema patients to experience depression, due to physical discomfort, emotional distress and lower quality of life. Anderson, Your safe choice Medical Center Specifications and Equipment The operating room is equipped with Mitaka microscopes, of which there are only four in Taiwan. They have a resolution of up to 16 million pixels and can magnify 42 times optically. They are very suitable for the anastomosis of lymphatic vessels and veins of 0.5 mm and are often used in lymphatic venous anastomosis, such as preoperative evaluation and intraoperative evaluation of the permeability of sutures, making the operation more stable and safe. Surgical Techniques 1 Lymphaticovenous Anastomosis, LVA LVA is an advanced minimally invasive super-microsurgical technique used to relieve lymphedema. During the procedure, Dr. Cheng will make small incisions, which expose lymphatic channels and small veins just beneath the skin. Learn more 2 Vascularized Lymph Node Flap Transfer, VLNT In some cases, surgery may be performed to alleviate swelling and reduce symptoms. Dr. Cheng has developed a unique technique that involves lymph node transfer. During the procedure, Dr. Cheng transfers lymph node flap to distal recipient site – dorsal wrist in the upper extremity or ankle in the lower extremity. Learn more Case 61-year-old female with breast cancer-related lymphedema in the right upper limb Before Surgery: This is a 61-year-old female who had suffered from breast cancer-related lymphedema of the right upper extremity for 10 years after mastectomy, axillary 19 lymph nodes dissection, and radiotherapy. With the combined use of compression garments and the treatment of complete decongestive therapy, she had developed 2 episodes of cellulitis per year. After Surgery: At 75- months follow-up, the circumferential reduction rates of the affected limb circumference without the use of compression garments were 100% and 40% above and below the elbow, respectively. 53-year-old patient, right upper limb lymphedema clinical grade II Before Surgery: A 53-year-old patient with grade II breast cancer-related lymphedema of the right upper extremity for 36 months after modified radical mastectomy, axillary lymph node dissection, and radiation. She developed 2 episodes of cellulitis per year and was refractory to conservative decongestive therapy. After Surgery: At 36- months follow-up, the circumferential reduction rates of the affected limb circumference without the use of compression garments were 100% and 85% above and below the elbow, respectively. 39-year-old female, left upper limb lymphedema, grade 1 Before Surgery: This is a 39-year-old female with left upper limb lymphedema for 6- months after left mastectomy and axillary 31 lymph nodes dissection and radiation. After Surgery: At a 3- months of follow-up, the circumferential reduction rates of the affected limb without the use of compression garments were 35% and 60% above the elbow and below the elbow, respectively. 49-year-old female, right upper limb lymphedema, grade 1 Before Surgery: This is a 49-year-old female with right upper limb lymphedema for 6- months after right mastectomy and axillary lymph nodes dissection and radiation. After Surgery: At a 20- months of follow-up, the circumferential reduction rates of the affected limb without the use of compression garments were 85% and 60% above the elbow and below the elbow, respectively. Recommended reading journal Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Lin CH, Ali R, Chen SC, Wallace C, Chang YC, Chen HC, Cheng MH. Plast Reconstr Surg. 2009 Apr;123(4):1265-75 https://www.ncbi.nlm.nih.gov/pubmed/19337095 Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes.. Cheng MH, Chen SC, Henry SL, Tan BK, Lin MC, Huang JJ. Plast Reconstr Surg. 2013 Jun;131(6):1286-98. https://www.ncbi.nlm.nih.gov/pubmed/23714790 Outcomes of Lymphedema Microsurgery for Breast Cancer-related Lymphedema With or Without Microvascular Breast Reconstruction. Engel H, Lin CY, Huang JJ, Cheng MH. Ann Surg. 2017 Jun 7 https://www.ncbi.nlm.nih.gov/pubmed/28594742 Greater Omental Lymph Node Flap for Upper Limb Lymphedema with Lymph Nodes-depleted Patient. Chu YY, Allen RJ Jr, Wu TJ, Cheng MH. Plast Reconstr Surg Glob Open. 2017 Apr 25;5(4):e1288. https://www.ncbi.nlm.nih.gov/pubmed/28507857 The Submental versus Groin Vascularized Lymph Node Transfer Flaps: A Head-to-Head Comparison of Surgical Outcomes for Breast Cancer Related Lymphedema Ho OA, Lin CY, Cheng MH. Plast Reconstr Surg Glob Open. 2018 [Epub ahead of print] Contact Dr. Cheng For A Consultation If you have Breast Cancer Related Lymphedema and would like to know more about the most advanced treatments, contact Dr. Cheng. Internationally recognized as a leading lymphedema specialist, Dr. Cheng can discuss treatment options, based on your individual case. Dr. Cheng is a member of the American Society of Reconstructive Microsurgery and has performed numerous VLN surgeries on breast cancer survivors and other lymphedema patients. Learn more
- Lower Extremity Lymphedema | 安德森整形外科診所
Lower Extremity Lymphedema 下肢淋巴水腫:成因與症狀、淋巴水腫診斷、治療方式 What is Lymphedema of The Legs? Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery Lower Extremity Lymphedema? The lower extremity lymphedema has a 10-49% occurrence in patients who suffer from gynecological cancers with pelvic lymph node dissection and radiation. Higher body mass index, a greater number of pelvic lymph node removal, and radiation are the top risk factors for lower extremity lymphedema caused by parasite infection (Filariasis). Primary lymphedema patients with unknown etiology for symptoms and signs are categorized by their ages of onset as congenital (less than 2 years), lymphedema praecox (2- 35 years), and lymphedema tadar (older than 35 years). The incidence is higher after cancer resection and lymph node dissection in vulva cancer followed by cervical and ovarian cancer. Recently, sentinel lymph node biopsy was selectively applied in gynecological cancer surgery to reduce the lower limb lymphedema. Symptoms of Leg Lymphedema Lymphedema then presents as chronic changes and swelling of the tissue and is often associated with adipogenesis or fibrotic changes in the lower limb as well. Severe fibrosis occurs with long-standing lymphedema due to the accumulation of protein-rich fluid in the interstitial spaces coupled with inflammation repeated bouts of cellulitis. It is common for lymphedema patients to experience depression, due to the physical discomfort, emotional distress and lowered quality of life. Diagnosis of Leg Lymphedema Dr. Ming-Huei Cheng developed a Cheng’s Lymphedema Grading tool to assess the severity of extremity lymphedema. Cheng Lymphedema Grading System is currently the most common used measurement, it is based on not only subjective criteria and clear objective findings that could facilitate discussions and meaningful comparison of the treatment proposed. The circumferential measurement is an objective analysis tool to assess the severity of lymphedema commonly by comparing the circumferential differences between the lymphedematous limb and the normal limb. Lymphoscintigraphy, computed tomography (CT), indocyanine green (ICG) lymphography, and magnetic resonance imaging (MRI) are other key diagnostic devices to determine the severity of lymphedema. The lymphoscintigraphy has been reported as the most effective indicator with 96% sensitive and 100% specific conclusion for diagnosing extremity lymphedema. The Taiwan Lymphoscintigraphy Staging systems was published in 2018 at Annals of Surgery. Lymphoscintigraphy computed tomography (CT) magnetic resonance imaging (MRI) indocyanine green (ICG) lymphography Treatment of Lower Extremity Treatments of lymphedema are aimed to control infection, to reduce the swelling of the extremity and to improve the quality of life. Basic treatments of lymphedema start with conservative physical therapy, including manual lymphatic drainage and compression bandage-centered decongestive lymphatic therapy. The efficacy of conservative physical therapy presents only when the patients are compliant with the treatment program. However, it also carries risks of intravascular cancer metastasis and thrombosis formation. Surgical treatments are indicated when first line conservative measures fail and when patients present with late stage disease. There are two main categories of surgical treatment: excisional and physiologic procedures. Excisional procedures are essentially a surgical reduction of excess fibro-adipose tissue in the affected limb while physiologic procedures reconstruct the lymphatic system to improve physiologic drainage. Surgical treatments are also “be cure and control”, the goals of treatment are similarly preventing progression of disease and reducing morbidities. Debulky surgery and circumferential suction-assisted lipectomy can be performed to reduce the severely, non-pitting lymphedematous extremity. More technical demanding surgeries, such as lymphaticovenous anastomosis and Free vascularized lymph node transfer The basic physiologic mechanism of the vascularized lymph node flap is that lymph is absorbed by the transferred lymph nodes and drained into a donor vein through natural lymphaticovenous connections inside a flap. The arterial flow from the recipient artery to the vascularized lymph node flap provides the driving force for venous return and hence, continuous lymph drainage. We report the transfer of a vascularized submental lymph node flap to the ankle is a novel approach for the effective treatment of lower extremity lymphedema. There was no donor site morbidity. At a mean follow-up of 8.7 ± 4.2 months, the mean reduction of the leg circumfer- ence was 64±11.5% above the knee, 63.7±34.3% below the knee and 67.3±19.2% above the ankle. All of the patients did not use compression garments post-operatively! Anderson, Your safe choice Medical Center Specifications and Equipment The operating room is equipped with Mitaka microscopes, of which there are only four in Taiwan. They have a resolution of up to 16 million pixels and can magnify 42 times optically. They are very suitable for the anastomosis of lymphatic vessels and veins of 0.5 mm and are often used in lymphatic venous anastomosis, such as preoperative evaluation and intraoperative evaluation of the permeability of sutures, making the operation more stable and safe. Recommended reading journal A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Cheng MH, Huang JJ, Nguyen DH, Saint-Cyr M, Zenn MR, Tan BK, Lee CL. Gynecol Oncol. 2012 Jul;126(1):93-8. https://www.ncbi.nlm.nih.gov/pubmed/22516659 Simultaneous Bilateral Submental Lymph Node Flaps for Lower Limb Lymphedema Post Leg Charles Procedure. Ito R, Lin MC, Cheng MH. Plast Reconstr Surg Glob Open. 2015 Sep 15;3(9):e513. https://www.ncbi.nlm.nih.gov/pubmed/26495226 Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites and outcomes. Pappalardo M, Patel K, Cheng MH. J Surg Oncol. 2018 Jun;117(7):1420-1431. https://www.ncbi.nlm.nih.gov/pubmed/29572824 Correlation between Quantity of Transferred Lymph Nodes and Outcome in Vascularized Submental Lymph Node Flap Transfer for Lower Limb Lymphedema. Gustafsson J, Chu SY, Chan WH, Cheng MH. Plast Reconstr Surg. 2018 Jul 10. https://www.ncbi.nlm.nih.gov/pubmed/30020232 Contact Dr. Cheng For A Consultation If you have Breast Cancer Related Lymphedema and would like to know more about the most advanced treatments, contact Dr. Cheng. Internationally recognized as a leading lymphedema specialist, Dr. Cheng can discuss treatment options, based on your individual case. Dr. Cheng is a member of the American Society of Reconstructive Microsurgery and has performed numerous VLN surgeries on breast cancer survivors and other lymphedema patients. Learn more
- Patient's Testimonials | 安德森整形外科診所
Patient Testimonials Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery 病患感言 病患感言 Play Video Share Whole Channel This Video Facebook Twitter Pinterest Tumblr Copy Link Link Copied Search videos Search video... Now Playing Lymphedema Treatment Testimony: Canadian Patient at A+ Surgery Clinic, Taipei, Taiwan"Video Content: 09:51 Play Video Now Playing Lymphedema Treatment Testimony:In addition to excellent medical care, also enjoys Taiwanese cuisine 04:27 Play Video Now Playing Mr. William from Australia 05:50 Play Video
- Accommodation Information | 安德森整形外科診所
Accommodation Information Say Goodbye to Compression Garments after Dr. Cheng's Lymphedema Microsurgery From Taipei Main Station to A+ Surgery Clinic Transportation routes 點擊開啟Google map Take the bus Take bus number 63 and get off at Zhongshan Junior High School. Click to view bus routes Take bus number 49 and get off at the intersection of Minquan and Fuxing Roads. It's a 4-minute walk from there. Click to view bus routes Take the MRT Take the Bannan Line (Blue Line) from Taipei Main Station to Zhongxiao Fuxing Station. Then transfer to the Wenhu Line (Brown Line) to Zhongshan Junior High School Station. From Taoyuan International Airport to A+ Surgery Clinic Transportation routes Click to open Google Maps Take the bus Take bus number 63 and get off at Zhongshan Junior High School. Click to view bus routes Take bus number 49 and get off at the intersection of Minquan and Fuxing Roads. It's a 4-minute walk from there. Click to view bus routes Take the MRT Take the Bannan Line (Blue Line) from Taipei Main Station to Zhongxiao Fuxing Station. Then transfer to the Wenhu Line (Brown Line) to Zhongshan Junior High School Station. A+ Surgery Clinic is located on Fuxing North Road in Songshan District, Taipei City. Below are some hotel information around the neighborhood, providing various options for your stay. 15 minutes walking distance Mandarin Oriental Taipei No. 158 Dunhua North Road Taipei Read More 6 minutes by car HOTEL METROPOLITAN PREMIER TAIPEI No. 133, Section.3, Nanjing East. Road., Zhongshan District, Taipei Read More 6 minutes by car COURTYARD by Marriott Taipei Downtown No. 6, Section 3, Minsheng East Road, Zhongshan District, Taipei Read More 10 minutes walking distance BROTHER HOTEL No 255, Sect. 3, Nanjing East. Road, Songshan District, Taipei Read More 2 minutes walking distance Taipei Fullerton Hotel-Maison North No 315 Fuxing North. Road, Taipei Read More 2 minutes walking distance Guide Hotel No. 307, Fuxing North. Road., Songshan Dist., Taipei Read More 2 minutes walking distance Cityinn Hotel Plus Fuxing North Road Branch No 338 Fuxing North. Road, Taipei Read More 3 minutes walking distance Forever Inn 3F, No 282 Fuxing North. Road, Taipei Read More
- Publications | 安德森整形外科診所
鄭明輝教授發表66篇淋巴水腫論文和兩本教科書篇章,與國際學術醫界連結,為顯微重建整型外科及淋巴水腫世界權威 Publications Dr. Cheng's Publications in Lymphedema Microsurgery Dr. Cheng's Book and Chapter 1. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Lin CH, Ali R, Chen SC, Wallace C, Chang YC, Chen HC, Cheng MH. Vascularized lymph node transfer (VLNT) is a widely used and effective surgical treatment for lymphedema. Traditionally, lymph nodes have been transplanted to the axillary region to alleviate upper extremity lymphedema following breast cancer surgery. However, Professor Ming-Huei Cheng of Taiwan pioneered an innovative approach by transferring vascularized lymph nodes from the groin to the distal wrist, thereby improving lymphatic drainage and challenging the conventional practice of proximal lymph node transplantation. This groundbreaking technique has demonstrated remarkable clinical outcomes. According to long-term follow-up data over an average period of 56 months, patients who underwent lymph node transfer to the wrist achieved an average 50% reduction in the circumference of the affected arm. Published in 2009, this pioneering study became the first scientific publication to demonstrate the clinical effectiveness of distal lymph node transplantation. To date, it has been cited more than 439 times on Google Scholar, making a significant and lasting contribution to the advancement of vascularized lymph node transfer techniques. **Reference** *Plastic and Reconstructive Surgery.* 2009 Apr;123(4):1265–1275. DOI: 10.1097/PRS.0b013e31819e6529 https://www.ncbi.nlm.nih.gov/pubmed/19337095 2. A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Cheng MH, Huang JJ, Nguyen DH, Saint-Cyr M, Zenn MR, Tan BK, Lee CL. Professor Ming-Huei Cheng's second study on lymphedema treatment marked another groundbreaking advancement in the field. He pioneered an innovative surgical approach involving the transfer of vascularized submandibular lymph nodes to the ankle for the treatment of lower extremity lymphedema. Traditionally, treatment options for lower extremity lymphedema have primarily included compression stockings and lymphaticovenous anastomosis (LVA). However, these conventional approaches often provide limited benefits for patients with advanced or severe lymphedema. The submandibular lymph node transfer technique developed by Professor Cheng has demonstrated significant clinical outcomes, offering new hope to patients who have not responded adequately to conventional treatments. Since its publication, this pioneering study has received 330 citations on Google Scholar, highlighting its profound and lasting impact on both academic research and clinical practice in the field of lymphedema surgery. **Reference** *Gynecologic Oncology.* 2012 Jul;126(1):93–98. Epub 2012 Apr 17. DOI: 10.1016/j.ygyno.2012.04.017 https://www.ncbi.nlm.nih.gov/pubmed/22516659 3. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes.. Cheng MH, Chen SC, Henry SL, Tan BK, Lin MC, Huang JJ. **How Reliable and Effective Is Vascularized Lymph Node Transfer? Which Approach Yields Better Outcomes: Proximal or Distal Transplantation?** In 2013, Professor Ming-Huei Cheng published another significant study investigating the use of microsurgical vascularized groin lymph node transfer for the treatment of upper extremity lymphedema. The study provided a comprehensive and encouraging evaluation of groin lymph node anatomy, recipient site selection, and overall clinical outcomes. On average, more than six groin lymph nodes were successfully transferred during each procedure. Following a mean follow-up period of 39 months, patients demonstrated a 40% reduction in arm circumference, indicating consistent and favorable long-term treatment outcomes. These findings established an important foundation for the successful application of distal lymph node transfer in the treatment of breast cancer-related lymphedema, further supporting the clinical effectiveness of this innovative microsurgical approach. To date, the study has been cited 351 times on Google Scholar, reflecting its significant influence and contribution to the advancement of lymphedema surgery. 4. Preplanning Vascularized Lymph Node Transfer with Duplex Ultrasonography: An Evaluation of 3 Donor Sites. Patel KM, Chu SY, Huang JJ, Wu CW, Lin CY, Cheng MH. This study, published in 2014 by Dr. Patel, Professor Ming-Huei Cheng, and their colleagues, evaluated 68 patients with lymphedema undergoing vascularized lymph node transfer (VLNT). Using duplex ultrasonography, the researchers compared the anatomical structures and vascular characteristics of three commonly used lymph node donor sites: the submental region, groin, and supraclavicular region, providing valuable insights for preoperative surgical planning. Regarding lymph node quantity, both the submental and groin regions contained an average of more than three lymph nodes (3.1 and 3.3, respectively), whereas the supraclavicular region contained significantly fewer, averaging only 0.9 lymph nodes. A greater number of lymph nodes may contribute to improved functional recovery following transplantation. In terms of venous diameter, the groin region demonstrated the largest average diameter of approximately 12.2 mm. However, its deeper anatomical location makes surgical dissection relatively challenging. The submental region had an average venous diameter of approximately 2.9 mm. Although smaller than that of the groin, its well-defined anatomy facilitates reliable vascular anastomosis. In contrast, veins in the supraclavicular region were difficult to visualize consistently, potentially limiting their clinical applicability. Differences were also observed in flap thickness and volume. The groin flap was the thickest and largest in volume, followed by the submental flap, while the supraclavicular flap was the thinnest and smallest, potentially limiting its lymphatic drainage capacity. Although thicker flaps may result in an unnatural contour at the recipient site, they may also be associated with a higher density of lymph nodes. Considering these factors, the study recommended the submental region as the preferred donor site for vascularized lymph node transfer due to its moderate flap volume, reliable venous anatomy, and relatively high lymph node count. When the submental region is unsuitable, the groin may serve as an alternative donor site, although the potential risk of donor-site lower extremity lymphedema must be carefully considered. While the supraclavicular region offers certain aesthetic advantages due to its relatively concealed surgical scar, its anatomical and functional limitations make it less suitable as a routine donor site. This study highlights the importance of preoperative imaging in vascularized lymph node transfer. Duplex ultrasonography enables precise anatomical measurements and individualized donor-site assessment, helping surgeons identify the most appropriate lymph node donor site for each patient while enhancing surgical safety and optimizing clinical outcomes. **Reference** *Plastic and Reconstructive Surgery – Global Open.* 2014 Sep 8;2(8):e193. eCollection 2014 Aug. DOI: 10.1097/GOX.0000000000000105 https://www.ncbi.nlm.nih.gov/pubmed/25426376 5. The use of magnetic resonance angiography in vascularized groin lymph node transfer: an anatomic study. Dayan JH, Dayan E, Kagen A, Cheng MH, Sultan M, Samson W, Smith ML. J Reconstr Microsurg. 2014 Jan;30(1):41-5. doi: 10.1055/s-0033-1351668. Epub 2013 Sep 9. https://www.ncbi.nlm.nih.gov/pubmed/24019175 6. The mechanism of vascularized lymph node transfer for lymphedema: natural lymphaticovenous drainage. Cheng MH, Huang JJ, Wu CW, Yang CY, Lin CY, Henry SL, Kolios L. ### Professor Ming-Huei Cheng's Landmark 2014 Study: Uncovering the Mechanism Behind the Effectiveness of Vascularized Lymph Node Transfer In 2014, Professor Ming-Huei Cheng published a significant study in *Plastic and Reconstructive Surgery*, one of the most prestigious international journals in the field of plastic and reconstructive surgery. While three previous studies had already demonstrated the favorable clinical outcomes of vascularized lymph node transfer (VLNT) in treating lymphedema, this research went a step further by investigating the underlying mechanisms that make lymph node transplantation effective. Through animal experiments and intraoperative clinical observations, the study provided scientific explanations and evidence supporting the therapeutic effects of VLNT. In the animal experiments, the research team injected indocyanine green (ICG) into the distal portion of a lymph node-containing flap and observed the gradual movement of fluorescent signals toward the connected vein. When ICG was injected directly into the lymph node itself, fluorescence appeared in the vein within approximately 20 seconds. These findings demonstrated a functional connection between the transplanted lymph nodes and the venous system, supporting their ability to facilitate lymphatic drainage. In the clinical observations, patients undergoing transplantation of lymph node-containing flaps demonstrated similar findings. Following direct ICG injection into the lymph nodes, fluorescent signals were detected in the venous circulation within approximately 23 seconds, providing further evidence that lymph nodes can rapidly drain lymphatic fluid into the venous system. In contrast, when skin flaps without lymph node structures were examined, no fluorescence was detected in the veins even after one hour of observation. This striking difference further highlighted the essential role of lymph nodes in facilitating lymphatic drainage and reinforced the physiological mechanism underlying the effectiveness of VLNT. To date, this groundbreaking study has been cited 249 times on Google Scholar, reflecting its significant influence within the international scientific community. By providing both experimental and clinical evidence of lymphatic-to-venous drainage through transplanted lymph nodes, the research established an important scientific foundation for the continued development and advancement of vascularized lymph node transfer in lymphedema treatment. **Reference** *Plastic and Reconstructive Surgery.* 2014 Feb;133(2):192e–198e. DOI: 10.1097/01.prs.0000437257.78327.5b https://www.ncbi.nlm.nih.gov/pubmed/24469190 7. Developing a Lower Limb Lymphedema Animal Model with Combined Lymphadenectomy and Low-dose Radiation. Yang CY, Nguyen DH, Wu CW, Fang YH, Chao KT, Patel KM, Cheng MH. Historically, research on lymphedema has been relatively limited. To develop more effective treatment strategies, it is essential to gain a comprehensive understanding of the anatomical structures and physiological mechanisms of the lymphatic system, as well as the underlying pathophysiology of lymphedema. Such knowledge is fundamental to establishing reliable experimental models and advancing the evaluation and development of therapeutic approaches. To address this need, Professor Ming-Huei Cheng and his research team published a study in 2014 describing the development of a mouse model of lower extremity lymphedema. The model combined lymph node dissection at two anatomical sites—the inguinal and popliteal regions—with low-dose irradiation (20 Gy), successfully inducing stable and measurable chronic lower extremity lymphedema. This experimental model demonstrated several important advantages, including high reproducibility, low mortality, and significant limb swelling. Through technetium-99m (Tc-99m) lymphoscintigraphy and micro-computed tomography (micro-CT) volumetric measurements, the researchers were able to comprehensively characterize the physiological and anatomical changes associated with impaired lymphatic function. This groundbreaking study established a valuable experimental platform for evaluating future lymphedema treatments in animal models. It also provided an important scientific foundation for subsequent preclinical investigations and the advancement of clinical research in lymphedema management. **Reference** https://www.ncbi.nlm.nih.gov/pubmed/25289315 8. Vascularized lymph node flap transfer and lymphovenous anastomosis for klippel-trenaunay syndrome with congenital lymphedema. Qiu SS, Chen HY, Cheng MH. Individualized Surgical Management of Congenital Lymphedema Associated with Klippel-Trenaunay Syndrome This study presents a rare clinical case of congenital lymphedema associated with Klippel-Trenaunay syndrome (KTS). The patient exhibited bilateral lower extremity lymphedema accompanied by superficial venous malformations, representing a highly complex and challenging clinical condition. Based on the differences in disease severity between the patient's lower extremities, Professor Ming-Huei Cheng and his research team developed an individualized surgical treatment strategy. Lymphovenous anastomosis (LVA) was performed on the right lower extremity, where symptoms were relatively mild, while vascularized lymph node transfer (VLNT) was performed on the left lower extremity, which was more severely affected. The postoperative outcomes were encouraging, with significant improvements in swelling in both lower extremities, a low rate of recurrence, a marked reduction in infectious episodes, and an overall improvement in the patient's quality of life. These findings demonstrated the complementary roles and clinical applicability of LVA and VLNT in managing complex lymphedema. This case highlights the fact that congenital lymphedema is frequently associated with additional vascular or developmental abnormalities, making both diagnosis and treatment particularly challenging. Therefore, comprehensive preoperative clinical evaluation and detailed imaging assessments are essential for developing an appropriate treatment plan. For patients with complex presentations, surgical approaches should be carefully selected according to the location and severity of the affected areas, as well as the condition of the surrounding tissues, rather than relying on a single surgical technique. Beyond providing valuable clinical insights into the management of complex congenital lymphedema, this study also reflects Professor Cheng's contributions to integrating clinical assessment with advanced diagnostic imaging. Through the development and application of individualized surgical strategies, this research has helped expand more effective and precise treatment options for patients with lymphedema complicated by multiple associated abnormalities. **Reference** *Plastic and Reconstructive Surgery – Global Open.* 2014 Jul 9;2(6):e167. eCollection 2014 Jun. DOI: 10.1097/GOX.0000000000000099 https://www.ncbi.nlm.nih.gov/pubmed/25289360 9. From theory to evidence: long-term evaluation of the mechanism of action and flap integration of distal vascularized lymph node transfers. Patel KM, Lin CY, Cheng MH. Understanding the Mechanisms and Clinical Effectiveness of Distal Vascularized Lymph Node Transfer This study, published by Professor Ming-Huei Cheng and his research team in the *Journal of Reconstructive Microsurgery*, provides important insights into the physiological mechanisms and clinical integration of distal vascularized lymph node transfer (VLNT) through long-term clinical follow-up and experimental evaluation. Traditionally, vascularized lymph node transfer has been performed at proximal recipient sites, such as the axillary or inguinal regions, based on the concept of restoring local lymphatic drainage pathways. However, clinical observations have demonstrated that transferring lymph nodes to distal sites, such as the wrist or ankle, can also effectively alleviate limb lymphedema, despite an incomplete understanding of the underlying mechanisms. This study aimed to address this important knowledge gap. The research team identified 20 patients from the Chang Gung Memorial Hospital database who had undergone distal VLNT and had been followed for more than one year, with a mean follow-up period of 27.3 months. Recipient sites included the wrist, elbow, and ankle, while donor lymph nodes were harvested from either the groin or submental region. Following surgery, indocyanine green (ICG) fluorescence imaging was performed by injecting ICG proximal to the transplanted lymph nodes to evaluate whether the fluorescent tracer could reach the transferred lymph nodes. The results demonstrated that all patients exhibited distal movement of ICG into the transplanted lymph nodes, indicating functional integration between the transferred lymph nodes and the surrounding lymphatic system. More importantly, a significant negative correlation was observed between the ICG latency period and the degree of improvement in limb circumference. Patients with shorter fluorescence transit times demonstrated greater improvements in lymphedema. The study further suggested that the effectiveness of distal VLNT may be related to damage to the native proximal lymphatic pathways caused by previous surgery or radiation therapy, which can limit the benefits of proximal reconstruction. In contrast, distal regions may retain functional lymphatic networks and venous structures. Through intrinsic lymphovenous connections, transplanted lymph nodes may facilitate the direct drainage of lymphatic fluid into the venous circulation, providing an alternative and potentially more effective pathway for lymphatic drainage. Notably, this distal flow pattern was observed even when patients were in a supine position, under gravity-neutral conditions. This finding suggests that the observed lymphatic drainage was not solely dependent on gravity but reflected genuine physiological interactions between the lymphatic and venous microcirculatory systems. Finally, the study highlighted the feasibility and sustained clinical effectiveness of distal lymph node transfer to nonanatomical recipient sites. The authors suggested that conventional proximal transplantation strategies should be reconsidered in patients with advanced or severe lymphedema, with distal VLNT representing a potentially valuable functional treatment option. By providing important mechanistic evidence supporting distal lymph node transplantation, this research has contributed to a deeper understanding of lymphatic drainage physiology and opened new perspectives for surgical decision-making, treatment planning, and postoperative evaluation in lymphedema management. J Reconstr Microsurg. 2015 Jan;31(1):26-30. doi: 10.1055/s-0034-1381957. Epub 2014 Aug 19. https://www.ncbi.nlm.nih.gov/pubmed/25137504 10. Quantity of lymph nodes correlates with improvement in lymphatic drainage in treatment of hind limb lymphedema with lymph node flap transfer in rats. Nguyen DH, Chou PY, Hsieh YH, Momeni A, Fang YH, Patel KM, Yang CY, Cheng MH. Microsurgery. 2016 Mar;36(3):239-45. doi: 10.1002/micr.22388. Epub 2015 Feb 25. https://www.ncbi.nlm.nih.gov/pubmed/25715830 Understanding the Mechanisms and Clinical Effectiveness of Distal Vascularized Lymph Node Transfer This study, published by Professor Ming-Huei Cheng and his research team in the *Journal of Reconstructive Microsurgery*, provides important insights into the physiological mechanisms and functional integration of distal vascularized lymph node transfer (VLNT) through long-term clinical follow-up and experimental evaluation. Traditionally, vascularized lymph node transfer has been performed at proximal recipient sites, such as the axillary or inguinal regions, based on the concept of restoring local lymphatic drainage pathways. However, clinical observations have demonstrated that transferring lymph nodes to distal sites, such as the wrist or ankle, can also effectively alleviate limb lymphedema, despite an incomplete understanding of the underlying mechanisms. This study aimed to address this important knowledge gap. The research team identified 20 patients from the Chang Gung Memorial Hospital database who had undergone distal VLNT and had been followed for more than one year, with a mean follow-up period of 27.3 months. Recipient sites included the wrist, elbow, and ankle, while donor lymph nodes were harvested from either the groin or submental region. Following surgery, indocyanine green (ICG) fluorescence imaging was performed by injecting ICG proximal to the transplanted lymph nodes to evaluate whether the fluorescent tracer could reach the transferred lymph nodes. The results demonstrated that all patients exhibited distal movement of ICG into the transplanted lymph nodes, indicating functional integration between the transferred lymph nodes and the surrounding lymphatic system. More importantly, a significant negative correlation was observed between the ICG latency period and the degree of improvement in limb circumference. Patients with shorter fluorescence transit times demonstrated greater improvements in lymphedema. The study further suggested that the effectiveness of distal VLNT may be related to damage to the native proximal lymphatic pathways caused by previous surgery or radiation therapy, which can limit the benefits of proximal reconstruction. In contrast, distal regions may retain functional lymphatic networks and venous structures. Through intrinsic lymphovenous connections, transplanted lymph nodes may facilitate the direct drainage of lymphatic fluid into the venous circulation, providing an alternative and potentially more effective pathway for lymphatic drainage. Notably, this distal flow pattern was observed even when patients were in a supine position, under conditions that minimized the influence of gravity. This finding suggests that the observed lymphatic drainage was not solely dependent on gravity but reflected physiological interactions between the lymphatic and venous microcirculatory systems. Finally, the study highlighted the feasibility and sustained clinical effectiveness of distal lymph node transfer to nonanatomical recipient sites. The authors suggested that conventional proximal transplantation strategies should be reconsidered in patients with advanced or severe lymphedema, with distal VLNT representing a potentially valuable functional treatment option. By providing important mechanistic evidence supporting distal lymph node transplantation, this research has contributed to a deeper understanding of lymphatic drainage physiology and opened new perspectives for surgical decision-making, treatment planning, and postoperative evaluation in lymphedema management. **Reference** *Journal of Reconstructive Microsurgery.* 2015 Jan;31(1):26–30. Epub 2014 Aug 19. DOI: 10.1055/s-0034-1381957 https://www.ncbi.nlm.nih.gov/pubmed/25137504 11. Simultaneous Bilateral Submental Lymph Node Flaps for Lower Limb Lymphedema Post Leg Charles Procedure. Ito R, Lin MC, Cheng MH. Bilateral Vascularized Submental Lymph Node Transfer for Severe Lower Extremity Lymphedema Following the Charles Procedure This clinical case report, published in 2015, describes a 59-year-old woman who developed chronic left lower extremity lymphedema following treatment for endometrial cancer. Despite previously undergoing the Charles procedure, which involves extensive removal of the skin and subcutaneous tissue of the affected lower leg followed by skin grafting, the patient continued to experience recurrent infections and progressive worsening of lymphedema. To address this challenging condition, Professor Ming-Huei Cheng and his research team developed an innovative surgical approach involving the simultaneous transfer of bilateral vascularized submental lymph node flaps to two different recipient sites. One lymph node flap was transplanted to the ankle to improve lymphatic drainage and reduce recurrent foot infections and cellulitis. The other flap was transferred to the distal thigh near the knee to enhance lymphatic drainage in the thigh region. Following surgery, the patient experienced remarkable clinical improvements, including the resolution of recurrent infections, a significant reduction in limb circumference, and the elimination of the need for compression stockings. These improvements contributed to a substantial enhancement in her overall quality of life. This case demonstrated that bilateral vascularized submental lymph node transfer may represent an effective treatment option for patients with severe, refractory lower extremity lymphedema, particularly those who continue to experience disease progression and recurrent infections despite previous treatment with the Charles procedure. By introducing an individualized surgical strategy involving lymph node transplantation to multiple recipient sites, this study provided valuable clinical insights into the management of advanced lymphedema and expanded the potential applications of vascularized lymph node transfer in complex reconstructive surgery. **Reference** *Plastic and Reconstructive Surgery – Global Open.* 2015 Sep 15;3(9):e513. eCollection 2015 Sep. DOI: 10.1097/GOX.0000000000000489 https://www.ncbi.nlm.nih.gov/pubmed/26495226 12. Successful treatment of early-stage lower extremity lymphedema with side-to-end lymphovenous anastomosis with indocyanine green lymphography assisted. Ito R, Wu CT, Lin MC, Cheng MH. Microsurgery. 2016 May;36(4):310-5. doi: 10.1002/micr.30010. Epub 2015 Dec 15. https://www.ncbi.nlm.nih.gov/pubmed/26666982 Understanding the Mechanisms and Clinical Effectiveness of Distal Vascularized Lymph Node Transfer This study, published by Professor Ming-Huei Cheng and his research team in the *Journal of Reconstructive Microsurgery*, investigated the underlying mechanisms and functional integration of distal vascularized lymph node transfer (VLNT) through long-term clinical follow-up and experimental evaluation. Traditionally, vascularized lymph node transfer has been performed at proximal recipient sites, such as the axillary or inguinal regions, based on the concept of restoring local lymphatic drainage pathways. However, clinical observations have demonstrated that transferring lymph nodes to distal sites, such as the wrist or ankle, can also effectively alleviate limb lymphedema, despite an incomplete understanding of the underlying mechanisms. This study aimed to address this important knowledge gap. The research team identified 20 patients from the Chang Gung Memorial Hospital database who had undergone distal VLNT and had been followed for more than one year, with a mean follow-up period of 27.3 months. Recipient sites included the wrist, elbow, and ankle, while donor lymph nodes were harvested from either the groin or submental region. Following surgery, indocyanine green (ICG) fluorescence imaging was performed by injecting ICG proximal to the transplanted lymph nodes to evaluate whether the fluorescent tracer could reach the transferred lymph nodes. The results demonstrated that all patients exhibited distal movement of ICG into the transplanted lymph nodes, indicating functional integration between the transferred lymph nodes and the surrounding lymphatic system. More importantly, a significant negative correlation was observed between the ICG latency period and the degree of improvement in limb circumference. Patients with shorter fluorescence transit times demonstrated greater improvements in lymphedema. The study further suggested that the effectiveness of distal VLNT may be related to damage to the native proximal lymphatic pathways caused by previous surgery or radiation therapy, which can limit the benefits of proximal reconstruction. In contrast, distal regions may retain functional lymphatic networks and venous structures. Through intrinsic lymphovenous connections, transplanted lymph nodes may facilitate the direct drainage of lymphatic fluid into the venous circulation, providing an alternative and potentially more effective pathway for lymphatic drainage. Notably, this distal flow pattern was observed even when patients were in a supine position, under conditions that minimized the influence of gravity. This finding suggests that the observed lymphatic drainage was not solely dependent on gravity but reflected physiological interactions between the lymphatic and venous microcirculatory systems. Finally, the study highlighted the feasibility and sustained clinical effectiveness of distal lymph node transfer to nonanatomical recipient sites. The authors suggested that conventional proximal transplantation strategies should be reconsidered in patients with advanced or severe lymphedema, with distal VLNT representing a potentially valuable functional treatment option. By providing important mechanistic evidence supporting distal lymph node transplantation, this research has contributed to a deeper understanding of lymphatic drainage physiology and opened new perspectives for surgical decision-making, treatment planning, and postoperative evaluation in lymphedema management. **Reference** *Journal of Reconstructive Microsurgery.* 2015 Jan;31(1):26–30. Epub 2014 Aug 19. DOI: 10.1055/s-0034-1381957 https://www.ncbi.nlm.nih.gov/pubmed/25137504 13. Lymphedema surgery: Patient selection and an overview of surgical techniques. Allen RJ Jr, Cheng MH. Surgical Management of Lymphedema: The Importance of Patient Selection and Individualized Treatment Strategies This review article, published by Dr. Robert Allen Jr., Professor Ming-Huei Cheng, and their colleagues in the *Journal of Surgical Oncology*, systematically examined various surgical approaches to lymphedema treatment, emphasizing the critical importance of appropriate patient selection. The article highlighted that lymphedema cannot be effectively managed through a single surgical approach for all patients. Instead, treatment strategies should be carefully tailored according to disease stage, severity, and progression. Based on the Cheng Lymphedema Grading System, patients with Stage 0 lymphedema are generally considered to be in a potentially reversible phase, making rehabilitation and conservative management the preferred treatment options. Patients with Stage I and early Stage II lymphedema typically retain some functional lymphatic pathways, making them suitable candidates for lymphovenous anastomosis (LVA). This microsurgical technique allows lymphatic fluid to bypass obstructed lymphatic channels and drain directly into the venous circulation. In contrast, patients with late Stage II through Stage IV lymphedema often experience extensive lymphatic obstruction or fibrosis, limiting the effectiveness of LVA. For these patients, reconstructive procedures such as vascularized lymph node transfer (VLNT) may offer more appropriate therapeutic options. By implementing a stage-based treatment strategy, surgeons can facilitate clearer communication with patients, minimize the risk of selecting inappropriate surgical procedures, and improve the likelihood of favorable clinical outcomes. Since its publication, this review has been cited more than 159 times, reflecting its significant contribution to the field of lymphedema surgery. By consolidating the major surgical approaches available at the time and emphasizing individualized treatment planning, the article has provided valuable practical guidance for clinicians in selecting appropriate surgical interventions for patients with lymphedema. **Reference** *Journal of Surgical Oncology.* 2016 Jun;113(8):923–931. Epub 2016 Feb 5. Review. DOI: 10.1002/jso.24170 https://www.ncbi.nlm.nih.gov/pubmed/26846615 14. Surgical anatomy of the vascularized submental lymph node flap: Anatomic study of correlation of submental artery perforators and quantity of submental lymph node. Tzou CH, Meng S, Ines T, Reissig L, Pichler U, Steinbacher J, Pona I, Roka-Palkovits J, Rath T, Weninger WJ, Cheng MH. J Surg Oncol. 2017 Jan;115(1):54-59. doi: 10.1002/jso.24336. Epub 2016 Jun 23. https://www.ncbi.nlm.nih.gov/pubmed/27338566 Surgical Anatomy and Clinical Advantages of the Vascularized Submental Lymph Node Flap Vascularized lymph node transfer (VLNT) has been established as an effective surgical treatment for lymphedema, with numerous successful clinical outcomes reported. Professor Ming-Huei Cheng has extensively investigated the surgical anatomy of the submental lymph node flap, including its anatomical location, distribution of vascular perforators, and lymph node quantity, and has published his findings in scientific journals. This study was conducted collaboratively by Professor Cheng and Professor Zhou from Vienna, Austria. At the time of the research, Professor Zhou was a trainee under Professor Cheng's mentorship and has since become a prominent expert in the field of lymphedema treatment in Austria. The anatomical findings revealed that the submental region contains an average of approximately three relatively large lymph nodes, accompanied by approximately four consistent vascular perforators. These vascular structures provide reliable blood perfusion, allowing the flap to maintain an adequate blood supply even when transferred to distal recipient sites. Furthermore, the study demonstrated that the relevant neural anatomy is relatively consistent, with the nerves generally following a course superficial to the facial artery. This predictable anatomical relationship allows surgeons to identify and preserve these structures during flap dissection, thereby reducing the risk of nerve injury. Overall, the submental region offers approximately three suitable lymph nodes, a reliable vascular supply, and clearly identifiable neural structures that can be preserved during surgery. These anatomical advantages make the vascularized submental lymph node flap a valuable and reliable donor-site option for vascularized lymph node transfer in the surgical management of lymphedema. 15. The 5th world symposium for lymphedema surgery-Recent updates in lymphedema surgery and setting up of a global knowledge exchange platform. Loh CY, Wu JC, Nguyen A, Dayan J, Smith M, Masia J, Chang D, Koshima I, Cheng MH. ### The 5th World Symposium for Lymphedema Surgery: Advancing Global Collaboration and Surgical Innovation The 5th World Symposium for Lymphedema Surgery was held in 2016 at Chang Gung Memorial Hospital in Taiwan. Led by Professor Ming-Huei Cheng in collaboration with internationally renowned experts, including Professor Jaume Masia from Barcelona and Professor David Chang from Chicago, the symposium aimed to establish a global platform for knowledge exchange, integrating clinical experience, basic research, and advances in surgical techniques. The symposium featured multiple live surgical demonstrations, including lymphovenous anastomosis (LVA), vascularized lymph node transfer (VLNT), and the application of lymph node flaps harvested from various donor sites, such as the submental, supraclavicular, and omental regions. Through real-time surgical broadcasts and expert commentary, the event encouraged interactive discussions and provided participating surgeons with valuable opportunities to observe advanced microsurgical techniques and exchange clinical insights. The symposium also received support from the Editor-in-Chief of the *Journal of Surgical Oncology*, with high-quality scientific papers presented at the meeting subsequently published in the journal. Beyond serving as an important international platform for clinical and scientific collaboration, the symposium offered young surgeons valuable opportunities for direct observation, hands-on learning, and professional engagement. By bringing together leading specialists from around the world, the 5th World Symposium for Lymphedema Surgery contributed to the global advancement of lymphedema surgery and supported the continued growth and development of innovative techniques in plastic and reconstructive microsurgery. 16. The surgical anatomy of the supraclavicular lymph node flap: A basis for the free vascularized lymph node transfer. Steinbacher J, Tinhofer IE, Meng S, Reissig LF, Placheta E, Roka-Palkovits J, Rath T, Cheng MH, Weninger WJ, Tzou CH. J Surg Oncol. 2017 Jan;115(1):60-62. doi: 10.1002/jso.24346. Epub 2016 Jun 28. https://www.ncbi.nlm.nih.gov/pubmed/27353521 17. The 5th World Symposium for Lymphedema Surgery. Cheng MH, Koshima I, Chang DW, Masia J. J Surg Oncol. 2017 Jan;115(1):5. doi: 10.1002/jso.24383. Epub 2016 Jul 29. No abstract available. https://www.ncbi.nlm.nih.gov/pubmed/27473624 18. Platysma-sparing vascularized submental lymph node flap transfer for extremity lymphedema. Poccia I, Lin CY, Cheng MH. J Surg Oncol. 2017 Jan;115(1):48-53. doi: 10.1002/jso.24350. Epub 2017 Jan 6. https://www.ncbi.nlm.nih.gov/pubmed/28058777 Platysma-Sparing Vascularized Submental Lymph Node Flap Transfer for Extremity Lymphedema This study introduces a modified surgical technique for vascularized submental lymph node flap transfer that preserves the platysma muscle. In conventional procedures, partial resection of the platysma muscle may be required, potentially resulting in temporary lower lip weakness or an asymmetric smile. The modified technique was designed to preserve the medial portion of the platysma muscle while carefully identifying and protecting the marginal mandibular branch of the facial nerve under microscopic visualization. This approach allows patients to benefit from the therapeutic effects of vascularized lymph node transfer while minimizing the risk of postoperative lip movement abnormalities. Clinical comparisons demonstrated complete flap survival in both the conventional and modified surgical groups. However, no cases of nerve-related pseudoparalysis were observed in the modified group, which also demonstrated improved surgical efficiency. By preserving important muscular and neural structures, this innovative technique achieves a balance between functional outcomes and aesthetic considerations while reducing donor-site morbidity. These findings suggest that platysma-sparing vascularized submental lymph node flap transfer may provide a safer and more refined surgical option for patients undergoing treatment for extremity lymphedema. 19. A prospective clinical assessment of anatomic variability of the submental vascularized lymph node flap. Cheng MH, Lin CY, Patel KM. Anatomical Variations of the Vascularized Submental Lymph Node Flap: Implications for Surgical Safety and Clinical Outcomes This prospective clinical study, published in the *Journal of Surgical Oncology* in 2017, investigated anatomical variations of the vascularized submental lymph node (VSLN) flap, aiming to help surgeons perform flap dissection and transplantation more safely and efficiently. The study included 49 patients, of whom 42 provided complete anatomical data. The findings revealed considerable variations in the courses of the arteries and veins associated with the submental lymph node flap. The most common anatomical pattern, observed in approximately 31% of cases, involved both the artery and vein passing superior to the submandibular gland. Other variations included arteries traversing the gland, veins running inferior or adjacent to the gland, and the presence of two parallel dominant veins. These anatomical variations directly influenced the complexity and duration of flap dissection. In particular, procedures involving arteries passing through the submandibular gland required significantly longer operative times. On average, approximately two lymph nodes were identified within each flap. Interestingly, flaps with arteries traversing the gland tended to contain a greater number of identifiable lymph nodes. The study also highlighted the value of preoperative ultrasonography in accurately identifying lymph node locations and vascular pathways, potentially reducing the risk of inadvertent injury during surgical dissection. Overall, this research emphasized the substantial vascular anatomical variability of the submental lymph node flap. A thorough understanding of these variations, combined with appropriate preoperative imaging, can help both novice and experienced surgeons perform vascularized lymph node transfer with greater safety, precision, and efficiency. For patients with advanced lymphedema, particularly those classified as Cheng Stage III or IV, this anatomical knowledge may play an important role in surgical planning and contribute to improved clinical outcomes. **Reference** *Journal of Surgical Oncology.* 2017 Jan;115(1):43–47. Epub 2017 Jan 13. DOI: 10.1002/jso.24487 https://www.ncbi.nlm.nih.gov/pubmed/28083889 20. Greater Omental Lymph Node Flap for Upper Limb Lymphedema with Lymph Nodes-depleted Patient. Chu YY, Allen RJ Jr, Wu TJ, Cheng MH. Omental Vascularized Lymph Node Transfer: An Alternative Surgical Option for Upper Extremity Lymphedema Vascularized lymph node transfer (VLNT) using lymph nodes harvested from the groin or submental region is commonly performed for the treatment of upper extremity lymphedema. Among these approaches, the vascularized submental lymph node flap has generally demonstrated reliable clinical outcomes. However, certain patients may have clinical conditions that limit the use of these conventional donor sites. For example, a history of nasopharyngeal carcinoma with previous neck irradiation may make the submental region unsuitable for lymph node harvesting. Similarly, patients who have undergone unsuccessful groin lymph node transfer or lymphovenous anastomosis (LVA) may have limited options for further reconstructive procedures. For patients in whom conventional donor sites are unavailable or unsuitable, omental vascularized lymph node transfer may serve as an alternative surgical approach. This study reported a case of a patient who developed upper extremity lymphedema following breast cancer surgery. Because neither the groin nor the submental region was suitable as a donor site, the surgical team performed vascularized omental lymph node transfer. Following surgery, the patient experienced a significant reduction in upper extremity swelling, with an approximately 40% decrease in limb volume. This favorable clinical outcome demonstrated the potential feasibility and therapeutic value of omental lymph node transfer in selected patients with complex clinical conditions. One of the anatomical advantages of the omental lymph node flap is the presence of two sets of arterial and venous vascular systems, which may provide flexibility in vascular reconstruction. However, this approach also presents several limitations, including the need for an abdominal surgical incision, a relatively limited number of smaller lymph nodes, potentially less reliable venous drainage, and the absence of an attached skin paddle. Despite these limitations, this case highlights the potential role of vascularized omental lymph node transfer as an alternative treatment option for patients with upper extremity lymphedema when conventional lymph node donor sites are unsuitable or unavailable. **Reference** *Plastic and Reconstructive Surgery – Global Open.* 2017 Apr 25;5(4):e1288. eCollection 2017 Apr. DOI: 10.1097/GOX.0000000000001288 https://www.ncbi.nlm.nih.gov/pubmed/28507857 21. The surgical anatomy of the vascularized lateral thoracic artery lymph node flap-A cadaver study. Tinhofer IE, Meng S, Steinbacher J, Roka-Palkovits J, Györi E, Reissig LF, Cheng MH, Weninger WJ, Tzou CH. J Surg Oncol. 2017 Dec;116(8):1062-1068. doi: 10.1002/jso.24783. Epub 2017 Aug 7. Platysma-Sparing Vascularized Submental Lymph Node Flap Transfer for Extremity Lymphedema This study introduces a modified surgical technique for vascularized submental lymph node flap transfer that preserves the platysma muscle. Conventional surgical approaches often involve partial resection of the platysma, which may result in temporary lower lip weakness or smile asymmetry. The modified technique preserves the medial portion of the platysma muscle while carefully identifying and protecting the marginal mandibular branch of the facial nerve under microscopic visualization. This approach aims to maintain the therapeutic benefits of vascularized lymph node transfer while minimizing the risk of postoperative lip movement abnormalities. Clinical comparisons demonstrated complete flap survival in both the conventional and modified surgical groups. Notably, no cases of nerve-related pseudoparalysis were observed in the modified group, which also demonstrated greater surgical efficiency. By preserving important muscular and neural structures, this innovative technique achieves a balance between functional outcomes and aesthetic considerations while reducing donor-site morbidity. These findings suggest that platysma-sparing vascularized submental lymph node flap transfer may offer a safer and more refined surgical option for patients undergoing treatment for extremity lymphedema. 22. Visualization of Skin Perfusion by Indocyanine Green Fluorescence Angiography-A Feasibility Study. Steinbacher J, Yoshimatsu H, Meng S, Hamscha UM, Chan CS, Weninger WJ, Wu CT, Cheng MH, Tzou CH. Plast Reconstr Surg Glob Open. 2017 Sep 25;5(9):e1455. doi: 10.1097/GOX.0000000000001455. eCollection 2017 Sep. https://www.ncbi.nlm.nih.gov/pubmed/29062637 23. Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites and outcomes. Pappalardo M, Patel K, Cheng MH. J Surg Oncol. 2018 Jun;117(7):1420-1431. doi: 10.1002/jso.25034. Epub 2018 Mar 24. Review. https://www.ncbi.nlm.nih.gov/pubmed/29572824 24. Vascularized Lymph Node Transfer for Lymphedema. Schaverien MV, Badash I, Patel KM, Selber JC, Cheng MH. Semin Plast Surg. 2018 Feb;32(1):28-35. doi: 10.1055/s-0038-1632401. Epub 2018 Apr 9.Review. https://www.ncbi.nlm.nih.gov/pubmed/29636651 25. Accurate Prediction of Submental Lymph Nodes Using Magnetic Resonance Imaging for Lymphedema Surgery. Asuncion MO, Chu SY, Huang YL, Lin CY, Cheng MH. Plast Reconstr Surg Glob Open. 2018 Mar 23;6(3):e1691. doi: 10.1097/GOX.0000000000001691. eCollection 2018 Mar. https://www.ncbi.nlm.nih.gov/pubmed/29707451 26. Critical Ischemia Time, Perfusion and Drainage Function of Vascularized Lymph Nodes. Yang CY, HO OA, Cheng MH, Hsiao HY. Plast Reconstr Surg. 2018 Jun 12. doi: 10.1097/PRS.0000000000004673. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29927833 27. Correlation between Quantity of Transferred Lymph Nodes and Outcome in Vascularized Submental Lymph Node Flap Transfer for Lower Limb Lymphedema. Gustafsson J, Chu SY, Chan WH, Cheng MH. Plast Reconstr Surg. 2018 Jul 10. doi: 10.1097/PRS.0000000000004793. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30020232 28. Acoustic Radiation Force Impulse Elastography: Tissue Stiffness Measurement in Limb Lymphedema. Chan WH, Huang YL, Lin C, Lin CY, Cheng MH, Chu SY. Radiology. 2018 Aug 14:172869. doi: 10.1148/radiol.2018172869. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30106341 29. Lymph node transplantation for the treatment of lymphedema. Gould DJ, Mehrara BJ, Neligan P, Cheng MH, Patel KM. J Surg Oncol. 2018 Aug 21. doi: 10.1002/jso.25180. [Epub ahead of print] Review. https://www.ncbi.nlm.nih.gov/pubmed/30129675 30. Effectiveness of Vascularized Lymph Node Transfer for Extremity Lymphedema Using Volumetric and Circumferential Differences Gustafsson J, Chu SY, Chan WH, Cheng MH. Plast Reconstr Surg. 2018 Jul 10. doi: 10.1097/PRS.0000000000004793. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30020232 31. Lymphedema and concomitant venous comorbidity in the extremity: Comprehensive evaluation, management strategy, and outcomes. Sachanandani N S, Chu SY, Ho O A., Cheong CF, Lin CY, Cheng MH*. J Surg Oncol. 2018 Nov;118(6):941-952. doi: 10.1002/jso.25237. https://www.ncbi.nlm.nih.gov/pubmed/ ? term=Lymphedema+and+concomitant+venous+comorbidity+in+the+extremity%3A+Comprehensive+evaluation%2C+management+strategy%2C+and+outcomes 32. Outcomes of Vascularized Lymph Node Transfer and Lymphovenous Anastomosis for Treatmentof Primary Lymphedema. Cheng MH, Loh CYY, Lin CY. Plats Reconstr Surg Glob Open. 2018 Dec 20;6(12):e2056. https://journals.lww.com/prsgo/Fulltext/2018/12000/Outcomes_of_Vascularized_Lymph Node_Transfer_and.15.aspx 33. Comparisons of Submental and Groin Vascularized Lymph Node Flaps Transfer for BreastCancer-Related Lymphedema. Ho OA, Lin CY, Pappalardo M, Cheng MH. Plats Reconstr Surg Glob Open. 2018 Dec 13;6(12):e1923. https://journals.lww.com/prsgo/Fulltext/2018/12000/Comparisons_of_Submental_and_Groin_Vascularized.13.aspx 34. A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer. Sachanandani N S, Chu SY, Ho O A., Cheong CF, Lin CY, Cheng MH*. 35. Proposed pathway and mechanism of vascularized lymph node flaps. Ito R, Zelken J, Yang CY, Lin CY, Cheng MH. 這篇 2016 年發表於 Gynecologic Oncology 的研究由鄭明輝教授團隊主導,透過大鼠與人體實驗證實血管化淋巴結皮瓣(VLN)能有效吸收組織間液並將其導入靜脈,揭示了其「抽水幫浦」般的作用機制。實驗顯示,只有含淋巴結的皮瓣在浸泡含有足夠濃度蛋白質(≥3%)的螢光染劑溶液時,才會在靜脈中出現螢光訊號,證明淋巴液與蛋白質先經淋巴毛細管進入淋巴結,再透過高內皮小靜脈轉運至靜脈系統,從而完成引流。臨床上,接受下頷下淋巴結移植的病人皆在一年內獲得症狀改善。此研究首次清楚闡明了淋巴結移植的運作路徑與機制,已成為整形重建外科界廣泛引用的重要依據,並被引用超過 100 次。 Gynecol Oncol. 2016 Apr;141(1):182-8. doi: 10.1016/j.ygyno.2016.01.007. Epub 2016 Jan 7. https://www.ncbi.nlm.nih.gov/pubmed/26773469 36. Outcomes of Lymphedema Microsurgery for Breast Cancer-related Lymphedema With or Without Microvascular Breast Reconstruction. Ho OA, Lin CY, Pappalardo M, Cheng MH. Ann Surg. 2017 Jun 7. doi: 10.1097/SLA.0000000000002322. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28594742 37. Validity of the Novel Taiwan Lymphoscintigraphy Staging and Correlation of Cheng LymphedemaGrading for Unilateral Extremity Lymphedema. Cheng MH, Pappalardo M, Lin C, Kuo CF, Lin CY, Chung KC. Ann Surg. 2018 Sep;268(3):513-525. doi: 10.1097/SLA.0000000000002917. https://www.ncbi.nlm.nih.gov/pubmed/30004927 38. Dorsal Wrist Placement for Vascularized Submental Lymph Node Transfer Significantly Improves Breast Cancer-Related Lymphedema. Hattan A, Fries Charles Anton, BChir, FRCS, Cheng Ming-Huei. Plastic and Reconstructive Surgery - Global Open: 2019 Feb, 7(2): e2149. https://journals.lww.com/prsgo/Fulltext/2019/02000/Dorsal_Wrist Placement_for_Vascularized_Submental.14.aspx 39. Comparison of Outcomes between Side-to-End and End-to-End Lymphovenous Anastomoses for Early-Grade Extremity Lymphedema. Fahad K. Al-Jindan, Lin CY, Cheng MH. 40. Factors associated with professional healthcare advice seeking in breast cancer-related lymphedema. Lin CY, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):67-74. doi: 10.1002/jso.25523. Epub 2019 Jun 18. https://www.ncbi.nlm.nih.gov/pubmed/31209885 41. Lymphoscintigraphy for the Diagnosis of Extremity Lymphedema: Current Controversies Regarding Protocol, Interpretation and Clinical Application. Pappalardo M, Cheng MH. J Surg Oncol. 2020 Jan;121(1):37-47. doi: 10.1002/jso.25526. Epub 2019 Jun 18. https://www.ncbi.nlm.nih.gov/pubmed/31209893 這篇 2019 年發表於《Plastic and Reconstructive Surgery》的研究,針對早期肢體淋巴水腫,直接比較了 邊對端 (side-to-end, STE) 與 端對端 (end-to-end, ETE) 淋巴靜脈吻合術的臨床成果。研究共納入 58 位病人,其中 23 位接受 ETE,35 位接受 STE,所有患者皆在術前經螢光綠淋巴攝影確認有功能性的淋巴管。手術均由同一位資深外科醫師於高倍率顯微鏡下完成,平均追蹤時間超過 16 個月。 結果顯示,兩種吻合方式都能有效改善早期淋巴水腫,但 STE 的表現更佳。在肢體圍度減少方面,STE 組平均改善 3.2%,明顯優於 ETE 組的 2.2%。蜂窩性組織炎的發作次數在術後兩組皆大幅下降,從每年平均 1.7 次降至 0.7 次,但 STE 組的改善幅度更為明顯,尤其在上肢與下肢患者中皆有較佳的臨床效果。所有患者在手術後都能恢復日常生活,並且不再依賴壓力衣。 機制方面,研究指出 STE 的優勢在於 保留了淋巴管的連續性。這種吻合方式可以同時引流近端與遠端的淋巴液,維持淋巴管的收縮與功能;相對而言,ETE 需要切斷淋巴管,只能處理遠端的淋巴回流,因此功能上較受限制。 這項研究證實了淋巴靜脈吻合術對早期淋巴水腫確實有效,而邊對端吻合術在臨床效果上更具優勢,特別是在減少肢體腫脹與控制蜂窩性組織炎方面,為日後手術策略的選擇提供了有力的依據。 Plast Reconstr Surg. 2019 May 10. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/31188305 42. Intra-abdominal Chylovenous Bypass Treats Retroperitoneal Lymphangiomatosis. Chen C, Cheng MH et al. 這篇發表於《Journal of Surgical Oncology》的研究,探討 後腹膜淋巴管增生症(retroperitoneal lymphangiomatosis, RL) 伴隨淋巴水腫與腹水的治療策略。RL 屬於罕見的先天性淋巴異常,因後腹膜淋巴管異常增生導致乳糜性腹水(chylous ascites),病人常出現下肢淋巴水腫、營養不良、體重上升、免疫力下降,容易反覆感染甚至敗血症。診斷上需結合淋巴攝影、磁振造影(MRI)、單光子電腦斷層(SPECT)等影像學檢查。 研究回顧 2012 至 2018 年間 44 例原發性下肢淋巴水腫患者,其中 6 位被診斷為 RL(盛行率約 13.6%)。這些病人接受了 血管化淋巴結移植(VLNT) 治療下肢淋巴水腫,並針對乳糜性腹水進行 腹腔內邊對端乳糜靜脈繞道手術(chylovenous bypass, CVB)。手術方式是由一般外科進行腹部探查,找到乳糜外漏源頭,再由顯微外科將病灶處的淋巴流引流到卵巢靜脈或內髂靜脈。這項技術的挑戰性極高,需要跨科團隊合作。 臨床結果顯示,所有 6 位病人的 CVB 均保持通暢(其中 1 人需再吻合一次),乳糜性腹水完全解決,病人能恢復正常飲食與活動。手術後,下肢肢圍平均改善 4.2 公分(p=0.043),蜂窩性組織炎發作次數由每年 1.9 次顯著降至 0.1 次(p=0.04),生活品質評分從 3.4 提升到 5.7(p=0.023)。營養狀態(白蛋白)與體重則有輕度改善,但未達顯著差異。大多數病人在半年內可停止穿著壓力衣。 這項研究證實腹腔內邊對端乳糜靜脈繞道結合淋巴結移植,能有效處理 RL 所造成的乳糜性腹水與下肢淋巴水腫,顯著減少感染、改善肢體腫脹並提升生活品質。對於嚴重或先天性淋巴水腫合併腹水的病人,這項手術提供了一條可行且具生理性的治療途徑。J Surg Oncol. 2020 Jan;121(1):75-84. doi: 10.1002/jso.25514. Epub 2019 Jul 4. https://www.ncbi.nlm.nih.gov/pubmed/31273800 43. Lymphedema Microsurgery Reduces the Rate of Implant Removal for Patients Who Have Pre-existing Lymphedema and Total Knee Arthroplasty for Knee Osteoarthritis. Voravitvet TY, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):57-66. doi: 10.1002/jso.25517. Epub 2019 Jun 13. https://www.ncbi.nlm.nih.gov/pubmed/31197837 44. Clinical Features, Microbiological Epidemiology and Recommendations of Management for Cellulitis in Extremity Lymphedema. Rodriguez JR, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):25-36. doi: 10.1002/jso.25525. Epub 2019 Jul 2. https://www.ncbi.nlm.nih.gov/pubmed/31264724 45. Delayed Primary Retention Suture: A new technique to inset Vascularized Submental Lymph Node Transfer. Koide S, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):138-143. doi: 10.1002/jso.25520. Epub 2019 Jul 5. https://www.ncbi.nlm.nih.gov/pubmed/31276208 46. Long-Term Outcome of Lower Extremity Lymphedema Treated with Vascularized Lymph Node Flaps with Venous Complications. Koide S, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):129-137. doi: 10.1002/jso.25602. Epub 2019 Jun 27. https://www.ncbi.nlm.nih.gov/pubmed/31246288 47. Summary of hands-on supermicrosurgery course and live surgeries at 8th world symposium for lymphedema surgery. Pappalardo M, Cheng MH et al. J Surg Oncol. 2020 Jan;121(1):8-19. doi: 10.1002/jso.25619. Epub 2019 Jul 16. https://www.ncbi.nlm.nih.gov/pubmed/31309553 48. Introduction of the 8th World Symposium for Lymphedema Surgery. Cheng MH, Chang DW, Masia J, Koshima I. J Surg Oncol. 2020 Jan;121(1):7. doi: 10.1002/jso.25620. Epub 2019 Jul 9. https://www.ncbi.nlm.nih.gov/pubmed/31290156 49. Impacts of Arterial Ischemia or Venous Occ.usion on Vascularized Groin Lymph Nodes in a Rat Model. Tinhofer I. E., Yang CY, Chen C, Cheng MH. J Surg Oncol. 2020 Jan;121(1):153-162. doi: 10.1002/jso.25518. Epub 2019 May 31. https://www.ncbi.nlm.nih.gov/pubmed/31152457 50. Volumetric Differences in the Superficial and Deep Compartments of Patients with Secondary Unilateral Lower Limb Lymphedema. Chu SY, Cheng MH et al. Plast Reconstr Surg. (paper in press) 51. Efficacy validation of a lymphatic drainage device for lymphedema drainage in a rat model. Cheng MH, Yang CY, Tee R, Hong YT, Lu CC. J Surg Oncol. 2019 Dec;120(7):1162-1168. https://www.ncbi.nlm.nih.gov/pubmed/?term=Efficacy+validation+of+a+lymphatic+drainage+device+for+lymphedema+drainage+in+a+rat+model 52. Institutionalization of Reconstructive Lymphedema Surgery in Austria - Single Center Experience. Tzou CHJ, Cheng MH et al. J Surg Oncol. 2020 Jan; 121(1):91-99. https://www.ncbi.nlm.nih.gov/pubmed/?term=Institutionalization+of+Reconstructive+Lymphedema+Surgery+in+Austria+%E2%80%93+Single+Center+Experience 53. Comparisons of Manual Tape Measurement and Morphomics Measurement of Patients with Upper Extremity Lymphedema. Horbal SR, Chu SY, Cheng MH* et al. Plast Reconstr Surg Global Open. 2019 Oct 29;7(10): e2431 https://www.ncbi.nlm.nih.gov/pubmed/ ? 54. Characterization of limb lymphedema using the statistical analysis of ultrasound backscattering. Lee YL, Cheng MH et al. Quant Imaging Med Surg. 2020;10(1):48-56. 55. Simultaneous Ipsilateral Vascularized Lymph Node Transplantation and Contralateral Lymphovenous Anastomosis in Bilateral Different-Severities Extremity Lymphedema. Cheng MH*, Tee R, Chen C, Lin CY, Pappalardo M. Ann Surg Oncol. 2020 Jun 18. doi: 10.1245 56. ASO Author Reflection: Simultaneous Ipsilateral Vascularized Lymph Node Transplantation and Contralateral Lymphovenous Anastomosis in Bilateral Different-Severities Extremity Lymphedema. Horbal SR, Chu SY, Cheng MH* et al. Ann Surg Oncol. 2020 Jul 10. 57. Lymphedema microsurgery improved outcomes of pediatric primary extremity lymphedema. Cheng MH*, Liu TTF. Microsurgery, 2020 Jul 11. 58. Chylovenous bypass for mesenteric lymphangiomatosis: A case report. Chen C,Cheng MH*. J Surg Oncol. 2020 Jul 15. 59. Staging and clinical correlations of lymphoscintigraphy for unilateral gynecological cancerrelated lymphedema. Pappalardo M, Lin C, Ho OA, Kuo CF, Lin CY, Cheng MH". J Surg Oncol. 2020 Mar;121(3):422-434. 60. Morbidity of Marginal Mandibular Nerve Post Vascularized Submental Lymph Node Flap Transplantation. Chang Tommy NJ, Lee CH, Lin Jennifer AJ, Cheng MH*. J Surg Oncol. 2020 Dec;122(8):1747-1754 https://pubmed.ncbi.nlm.nih.gov/32869304/ 61. Simultaneous Ipsilateral Vascularized Lymph Node Transplantation and Contralateral Lymphovenous Anastomosis in Bilateral Different-Severities Extremity Lymphedema. Cheng MH*, Tee R, Chen C, Lin CY, Pappalardo M. Ann Surg Oncol. 2020 Jun 18. https://pubmed.ncbi.nlm.nih.gov/32556869/ 62. ASO Author Reflections: Simultaneous Ipsilateral Vascularized Lymph Node Transplantation and Contralateral Lymphovenous Anastomosis in Bilateral Different-Severities Extremity Lymphedema. Cheng MH*. Ann Surg Oncol. 2020 Dec;27(13):5277-5278. https://pubmed.ncbi.nlm.nih.gov/32651692/ 63. Response to letter to the editor: Evidence of Lymph Flow Amelioration on Indocyanine Green Lymphography after Vascularized Lymph Node Transfer. Cheng MH". Ann Surg Oncol. 2021 Jun;123(7):1641. https://pubmed.ncbi.nlm.nih.gov/33825195/ 64. Retrograde Manual Lymphatic Drainage following Vascularized Lymph Node Transfer to Distal Recipient Sites for Extremity Lymphedema: A Retrospective Study and Literature Review. Roka-Palkovits J, Lin CY, Tzou CH J, Tinhofer, Cheng MH*. Plast Reconstr Surg. 2021 Sep 1;148(3):425e-436e. https://pubmed.ncbi.nlm.nih.gov/34432699/ 65. Immediate Lymphovenous Bypass Treated Donor Site Lymphedema during Phalloplasty for Gender Dysphoria. Lin W, Safa B, Chen M, Cheng MH*. Plast Reconstr Surg Glob Open. 2021 Sep 17;9(9):e3822. https://pubmed.ncbi.nlm.nih.gov/34549009/ 66. Heparin-induced thrombocytopenia and thrombosis in primary lymphedema patients who underwent vascularized lymph node transplantations. Hsu SY, Lin CY, Cheng MH*. J Surg Oncol. 2022 Feb 2. https://pubmed.ncbi.nlm.nih.gov/35107827 Book: Principles and Practice of Lymphedema Surgery. Cheng MH, Chang DW, Patel KM (Editors). Elsevier Inc, Oxford, United Kingdom. ISBN: 978-0-323-29897-1. July 2015. Principles and Practice of Lymphedema Surgery 2nd Edition - January 7, 2021 Ming-Huei Cheng, David Chang, Ketan Patel. Paperback ISBN: 9780323694186 Book chapters: 16 1. Cheng MH, Nguyen DH, Huang JJ. Chapter 77: Vascularized Groin Lymph Node Flap for Treatment of Lymphedema. In: Perforator Flaps: Anatomy, Technique, & Clinical Applications. 2nd Edition. Blondeel PN, Morris SF, Hallock GG, and Neligan PC (Editors). Quality Medical Publishing, Inc. St. Louis, Missouri. 2013:1317-1328. 2. Cheng MH, Nguyen DH. Chapter 54: Lymph Node Transfer for Lymphedema. In: Operative Microsurgery. Boyd JB and Jones NF (Editors). McGraw-Hill, New York. 2015:672-682. 3. Tobbia D, Cheng MH. Vascularized Groin Lymph Node Flap Transfer for Post mastectomy Upper Limb Lymphedema. In Grabb's Encyclopedia of Flaps, 4th edition. Strauch B, Vasconez LO, Lee BT, and Herman CK (Editors). Wolters Kluwer, Philadelphia, PA, USA. 2015. 4. Tzou CHJ, Cheng MH. Transfer of lymph node tissue - my approach. In Oncoplastic and Reconstructive Management of the Breast: A Multidisciplinary Approach. CRC Press, Boca Raton, FL, 2015. 5. Cheng MH, Chang DW, Patel KM. Chapter 1: An introduction to principles and practice of lymphedema surgery. In Principles and Practice of Lymphedema Surgery. Cheng MH, Chang DW, Patel KM (Editors). Elsevier Inc, Oxford, United Kingdom. 2015 6. Nguyen DH, Cheng MH. Chapter 5: Laboratory study of lymphoma. In Principles and Practice of Lymphedema Surgery. Cheng MH, Chang DW, Patel KM (Editors). Elsevier Inc, Oxford, United Kingdom. 2015
- Lymphedema | 安德森整形外科診所
揮別壓力衣!鄭教授的獨門顯微手術 改善淋巴水腫帶來的不適:鄭明輝教授團隊、認識與診斷淋巴水腫和手術治療方案 About Lymphedema Microsurgery Dr. Cheng has been practicing Lymphedema microsurgery since 2000. He has invented some of the most advanced and effective surgical techniques to treat lymphedema. His ground-breaking innovation of vascularized submental lymph node (VSLN) and vascularized groin lymph node (VGLN) flap transfer to distal recipient site creates a physiologic drainage conduit to alter excess lymphatic fluid buildup and minimize the lymphedema associated side effects of tissue fibrosis and cellulitis. Dr. Cheng's lymphedema microsurgery outcomes show statistically significant circumferential reduction rates of affected limb circumference and impressive decreases in the episodes of cellulitis on the lymphedematous limb. His practice is the first in the world to immediately release patients from wearing compression garments postoperatively. Meet Dr. Cheng Ming-Huei Cheng MD, MBA, FACS, is a board certified plastic surgeon specialized in reconstructive microsurgery. Dr. Ming-Huei Cheng is listed among the most sought-after surgeons in the reconstructive microsurgery field. He has performed more than 2,000 microsurgical cases, including arm and leg reconstructions, head and neck reconstructions, breast reconstructions, extracranial-intracranial arterial bypasses, lymphovenous anastomosis and vascularized lymph node flap transfers. He finished a combined microsurgical and research fellow at Department of Plastic Surgery, MD Anderson Cancer Center, Houston, Texas in 1999. He is a member of the American Society for Reconstructive Microsurgery since 2003, a fellow of the American College of Surgeons since 2009, an international member of the American Society of Plastic Surgeons since 2012 and became an Adjunct Professor of the Department of Plastic Surgery at University of Michigan, USA in 2017. Learn more Dr. Cheng is Affiliated With 鄭教授淋巴水腫顯微外科手術學術里程碑 Dr.Cheng’s Academic Journey for Lymphedema Microsurgery 出處:取自《乳癌奇蹟治癒》方舟出版社 News Professor Ming-Huei Cheng, Named Among the "World's Top 2% Scientists" for 2026!」 Oct 8 We appreciate the recognition and affirmation from our patients in the United States. Every word of encouragement is our driving force! Dec 17, 2024 Professor Cheng was invited to attend the 49th Global Plastic Surgery Conference held in Porto, Portugal. Dec 10, 2024 1 2 3 4 5
- WSLS 2024 | 安德森整形外科診所
真實的故事和經驗分享來自於接受過我們服務的病患。透過他們的感言,您可以了解手術過程、恢復體驗以及最終結果,這些都將幫助您在考慮整型手術時更加安心與自信。我們以病患的滿意為榮,期待成為您變美旅程中的夥伴。 WSLS 2024 The 10th World Symposium for Lymphedema Surgery April 22-24, 2024 Endorsed by the World Society for Reconstructive Microsurgery! WELCOME Dear Esteemed Guests, Distinguished Colleagues, and Honored Speakers, It is with great pleasure and excitement that we extend a warm welcome to all of you to the 10 th World Symposium for Lymphedema Surgery, held at the prestigious Taipei Garden Hotel, Taipei, Taiwan from April 22 to April 24, 2024. This symposium represents a significant gathering of surgical professionals, researchers, and experts from around the world, all dedicated to advancing the field of lymphedema surgery. Over the next three days, we have meticulously curated a program that offers a platform for the exchange of knowledge, the exploration of cutting-edge research, and the sharing of invaluable experiences. One unique and groundbreaking feature of our symposium is the inclusion of the "Live Surgery Demonstrations" section. This pioneering component will allow attendees to witness, in real-time, surgical procedures related to lymphedema surgery, providing an extraordinary opportunity to observe the latest techniques and advancements firsthand. We believe this hands-on experience will greatly enhance the educational value of our symposium. Our distinguished speakers, who are leaders in the field of lymphedema surgery, will present their insights, innovations, and breakthroughs that promise to shape the future of patient care. We are honored to have such a wealth of expertise under one roof. Furthermore, we believe that the spirit of collaboration and networking is fundamental to progress in medicine. Therefore, we have designed this symposium to facilitate discussions, foster new collaborations, and nurture lasting professional relationships. We express our heartfelt gratitude to all those who have contributed to the realization of this symposium—our speakers, sponsors, partners, and, of course, each and every attendee. Your presence here makes this event truly special. As we embark on this enlightening journey together, we encourage you to engage actively, exchange ideas passionately, and, above all, take inspiration from the collective dedication to advancing the understanding and treatment of lymphedema. Once again, welcome to the World Symposium for Lymphedema Surgery. We anticipate an inspiring and productive symposium and look forward to the groundbreaking discoveries and friendships that will undoubtedly emerge. With warm regards, Co-Chairmen 10 th World Symposium for Lymphedema Surgery Ming-Huei Cheng, MD, David Chang, MD, and Jaume Masia, MD.
- 獲得補助款姊妹心得分享 | 安德森整形外科診所
獲得補助款姊妹心得分享 聽聽姐妹們的故事,或許能給妳一些方向 這是接受乳房重建補助的姊妹,與大家分享這份得到補助款喜悅的故事 小儀的故事 「乳癌」對女性而言,向來是諱疾忌醫居多,然而因飲食、環境荷爾蒙諸多因素,乳癌好發年齡層越趨年輕化,好發率逐年上升。拜現今醫學之賜,不管是早期發現提高治愈率,或是術後重建減少改變身體形象,重拾女性自信,皆能使其儘早回歸家庭、職場之中。 協會給予補助款的意義,不單只是金錢的紓困,它代表著一份溫暖、安慰及鼓勵,讓受惠者知道自己並不孤單,也有許多人在用行動支持著我們,謝謝這群用無私的愛默默付出的人! 小媚的故事 108年3月5日,我被醫生確診乳癌二期,突如其來的生病事實,打亂了我原本的生活,讓我一時不知所措,再半年即可達退休年資的工作被迫暫停,一切以治療優先,跟公司請了10個月的病假專心抗癌,三個孩子都還在國中、小學階段,為了我的家人,我要堅強面對!3月20日在台大新竹醫院進行全切及立即重建手術,4月15日開始了化療,7月底完成療程。 回首這段生病的旅程,我重新檢視自己為何會讓身體出狀況,我總是為了工作委曲求全,再累也自己默默承受;面對家庭中家人及小孩不聽話,總是很輕易的情緒上身,而讓彼此間處的不愉快,也讓親子關係緊繃。愛熬夜又吃垃圾食物,導致我的身體出了狀況,我得改變才能找回健康的自己。 108年10月1日,因復原狀況良好,我提前回到職場。因為這場疾病我開始改變!不再為了工作而累壞自己,每天規律運動均衡飲食,減少吃肉多吃蔬果,生活作息正常。面對家人及孩子,我學習放下,與他們和平相處,漸漸地我學會讓自己可以開心過生活。 轉眼生病已滿一年,感謝這段時間陪我走過的家人、朋友、同事,以及醫治我的醫護人員們,我的身體因為生病而有所不同,但我也因為重建讓外人看不出我有何不同,面對疾病我們都很脆弱,但也因此我學會堅強及勇敢去面對罹癌的事實。 小君的故事 我是一個普通的健康人,在2018年罹患乳癌,因為摸到在靠近乳房下方的位置有硬塊,當時的認知是覺得乳房附近有硬塊,並非是乳房疾病,直到檢查結果得知是乳癌時,霎那間晴天霹靂,很不想接受事實,心裡一直不斷地問:我才30幾歲這麼年輕,怎麼可能會是我?而且沒有家族病史,生活也很規律,更不用說還是個開朗的人,再怎麼想我都不可能會罹患乳癌! 但很不想相信也沒辦法改變這個事實,雖然無法接受檢查結果,還是要讓家人知道這個壞消息,不過還好家人都很樂觀的看待這個結果,所以自己也因為有家人的陪伴與支持,才勇於面對接受醫生的建議,執行乳房切除與重建手術。但因為腫瘤範圍近5公分左右大,所以必須做全切的手術,因為這樣才能避免有復發或轉移的可能性發生。不過還好;很幸運的是我及早發現,所以是屬於原位癌,在乳房切除後是不須再做化學治療的病人。 由於自己是做乳房全切手術,用自體組織皮瓣重建,起初也是沒辦法接受自己的身體,認為手術後的自己就不完整了,對自己有點沒自信,不敢面對自己,也認為很多行為活動都沒辦法像術前那樣了,還好重建的整形外科醫師有著專業的技術,不但讓術後的乳房外觀上與正常的沒有太大的不同,行為能力上也並沒有什麼影響。 因為是做顯微手術,所以不會像傳統手術那樣有著很大的疤痕在胸部上,但相對的手術費用就會高一些,而在這次重建補助上很幸運有通過補助資格的,因此很謝謝這次募款活動的所有人,因為有你們的熱心公益,才讓感同身受的我更有勇氣面對自己,讓國人更重視乳癌及預防。最後我認為最重要的事,就是家人與親友的關愛,醫師的專業都很重要,真的是支持的力量,才能讓自己在復原後能欣然的接受自己,在此很感謝我的整形外科醫師。 小晶的故事 在一次自我檢查中,發現了乳房有硬塊,後來到醫院檢查切片,證實是乳癌,當下真的無法接受,開始了一連串的治療之路。 開始腦袋一片空白,好幾天吃不好也睡不好,但在手術後,反而慢慢恢復了心情,相信醫生的建議,開始了6次的化療。化療的確會不舒服,但只要堅持數著剩下次數,一次次地減少,心裡就會支撐下去。帶假髮應該是過程中最不舒服的部分,現在化療結束一年多了,已經長出短髮了,這是最開心的事情。以前從沒想過,原來自己離生病這麼近,一場大病真的讓我學會更加珍惜身邊的每個人。 因為自己還年輕,所以選擇了重建,它讓我感覺可以比較有自信,不會讓手術的傷痕不斷提醒自己生病,可以恢復往常一樣的生活。雖然費用的確不便宜,但我覺得這是值得的,尤其對年輕患者來說。 也感謝乳房重建協會給予我們補助,也還好自己有保險,不然這一路的治療、檢查及暫停工作,的確也是負擔。也要告訴大家,若生病一定要積極治療,按照醫生的指示,辛苦一陣子,之後都可以繼續好好生活的! 小娟的故事 我是一位職業婦女,在我生病之前,就許多人的眼光來看,幾乎稱得上是標準的人生勝利組。做著自己喜歡的工作,有著美滿的家庭。一直到107年1月,我在右邊乳房摸到硬塊,很痛、多角形、很硬、慢慢變大,我開始懷疑它不是好東西!那時讓一向以自己人生為傲的我,突然悲傷而複雜的心情。過年後;老公帶我到高雄醫學院找侯明鋒醫師檢查,觸診完後馬上切片,幾天後病理切片確定診斷為 三期乳癌,需進行乳房切除手術,病理切片有淋巴轉移,只好接受化學治療,目前已完成所有治療,獲得重生!現在為一個普通的健康人。 抗癌的路上有著艱辛與挑戰,一路上感覺沒有喘息的時間,從發現至切片到安排開刀,8次的化療,25次的放療,還有18次的標靶。回想痛苦的治療過程期間經歷種種不適,掉髮、噁心、嘔吐、吃不下、白血球不足、口腔潰爛、牙齦腫脹、肛門裂傷、尿失禁、神志不清、精神恍惚...,我沒有間斷地告訴自己:不能放棄自己(我要活下去)!因此在親朋好友的關心及關愛下,我渡過一次難關,可說是苦盡甘來。隨著療程結束,體重止跌回升,回想起來都是因為家人及朋友們,持續的探望與鼓勵,增加我的勇氣,我非常非常的感謝他們。 現在的我每天都會運動,配合復健師做肌力的運動,也會吃三種以上的水果和蔬菜。人啊~高興是一天,憂愁也是一天,我現在只想開開心心的過每一天。相信醫生,好好配合,心情一定要好,保持正面愉快的心情,積極的接受治療,不要因為生病而影響自己的生活,現在只要自己舒服就行,這樣才能支持我讓生命延續下去。 小雅的故事 2016年聖誕節的時候,就是與它(腫瘤)的初次相見,看見它是一個在左邊胸骨附近突起硬塊,那時候誤以為是脂肪瘤(當時壓根沒想過這是惡性腫瘤),想到以前也看過爸爸的胸口上有個脂肪瘤,後來就把它手術切除,心想著應該是小事,等明年回台時門診手術處理掉。就這樣我從發現到正式回台灣的四個多月的日子中,依舊如往常般的上班、熬夜,連假日加班也帶客人看房子。這時也回想起二月份那時候大感冒一場,在家休養了兩週才康復一些,隨後的一個月,口角炎反覆發炎都沒有起色,那時我想到應該是準備回台太忙碌的關係,告訴自己沒關係再過幾週就回台灣,就這樣輕忽了。 4/11這天我回到了台北,過沒幾天就開始進行檢查,到社區家庭康寧醫院檢查,經歷了一個月一連串的檢查。被告知了是乳癌,當下我真傻眼,完全沒有癌症觀念的我,更是不能接受原以為是脂肪瘤,誰知道是惡性腫瘤!當下我告知檢查師:上次觸診醫生告知我大約是良性的,怎麼變成惡性的呢?當下實在太錯愕了,只好申請了報告,往台大黃俊昇醫生門診再次確認,就這樣又花一個月重新檢查後,確診左乳惡性腫瘤,台大醫院安排2017年7月25號開刀! 左側乳房全切除及立即單側重建計劃,入住了台大雙人病房,並開始打包五天四夜的行李,雖然沒有像出國旅遊時的興奮,但仍堅持帶自己的枕頭,讓這趟旅行有那麼一點溫暖。 記得從小就是個健康寶寶,連感冒都沒有幾次,更不用說全身麻醉如此大的手術,進到手術室前的擔心與大哭是一定有的,歷經了五個多小時手術非常成功。五天四夜的旅程在護理師及衛教術後的細心照顧下課程結束了,心中感謝所有在醫院中幫助我的醫護人員。術後的第一次整形外科門診,醫生看出了我內心的害怕與逃避,我們在診間閒聊時,不斷強調術後每天都要按摩矽膠乳房,讓我放下心防,告訴醫生看見重建過後的胸部其實沒很自信,無論形狀、觸感都是大不相同,而且實在太痛了!生理和心理都沒有調適過來,沒想到短短二個月我的人生與「假奶」畫上等號,就在接下來的術後一個月積極的按摩,每天都告訴我自己蔡依林可以,我怎麼可能辦不到! 術後第一次乳外門診,雖然經歷了手術、重建與復健,但到了這天要看化驗報告,還是免不了緊張。想著如果淋巴沒有感染,就可以免去化療的過程,就這樣走進診間,黃醫師一如往常的5分鐘安靜開場,第一句話就是腫瘤化驗結果,確認是二期荷爾蒙陽性,淋巴感染一顆建議化療。當下我就像是收到了兵單要去金門海軍陸戰隊般...好吧!告訴自己面對它、接受它、放下它。在當兵前一樣,新兵訓練不可少,我補修了基本的化療常識及注意事項課程,接下來就是剃光頭及裝上人工血管等入伍囉。第一次的化療,我簡直嚇到腿軟,也是開啟新人生的這門補修課程,老實說也是感謝自己獨立樂觀的個性,在16次的化療課程產生的副作用,新兵菜鳥遇到的狀況,我一個也沒有少。無論是嘔吐不適感,全身酸痛熱潮紅,到了嚴重時無法呼吸全身長滿痘子,以及後期指甲都發紫無法靈活運用。這些我都認為是只要面對了,就沒有無法克服的。就這樣,我這門選修課在五個月後順利畢業了,頭髮跟身上的毛髮,連不該長的腿毛也都在一年後的今天完好如初。所以很想告訴自己以及正在接受挑戰的病友們說一聲:沒有過不去的,只有先放棄。兵單來了就接下這項任務,任務結束。你可以很大聲的mission completed。 癌症或許的確打亂了自己原來回台的生涯計劃,以前我都無視健康重要性,更在一次機緣下收到重建協會的訊息,知道有補助辦法,也了解到台灣在社群補助上面的充足,讓病友都可以得到生活與精神上的幫助是很富足的,心中滿滿的感謝協助,謝謝! 小素的故事 大家好!自從106年至醫院做免費癌症篩檢後發現左邊乳房有鈣化斑點,在跑了兩間醫院檢查後,確定患有乳癌第零期,我的人生幾乎是黑白沮喪的,但我還是好好的配合醫生做治療,左邊乳房從局部切除手術、感染、住院清創到放射治療結束後,心想一切治療順利完成,後續定期追蹤即可,怎知在手術屆滿兩年時,我的左乳乳癌又復發! 我的主治醫師建議是否考慮左乳房全切一勞永逸,主治醫師看我一臉錯愕,於是跟我分析與建議,因為年齡與上班的關係,要不要考慮左乳全切重建手術,也幫我安排了整形外科醫生會談,由整形外科醫師分析與建議,手術方式分自體顯微皮瓣手術與矽膠重建,於是給了我時間與家人討論方案,個人也在乳癌醫療新知識群組裡了解一些重建資訊,最後在108年4月22日選擇了自體脂肪皮瓣顯微重建手術。 手術的時間長達20個小時手術,過程中身上多處大大小小的傷口非常疼痛,必須躺在加護病床上監控血流,因之前做過放射性治療,左乳房的血管有些微的堵塞,導致第二天又進了手術室做血管嫁接手術,以防手術後的乳房整個壞死。在整個乳房重建的過程中,不論是身體方面還是心理層面都是非常痛苦的,很感謝一路以來不斷給我鼓勵、加油打氣的家人朋友們,讓我有勇氣面對這一切,現在的我恢復相當好。 感謝! 我的醫療團隊讓我重回健康與自信! 小芳的故事 在我人生中才剛開始過著不用張羅孩子的生活起居,才開心過著自己想要的生活時,老天爺卻在此時此刻對我開了一個大玩笑! 當接到醫院 切片檢查結果的通知電話時,頓時腦筋一片空白無法思考,接下來的日子有很多消極的想法油然而生,此時幸好有身邊的親友陪伴鼓勵著,才能擦乾眼淚勇敢正視面對問題。 接下來的當務之急是尋求醫師的診療,當醫生給我全切或部分切除二選一的選項時,當時心中只有一個念頭,我必須選擇能把病症處理得最乾淨徹底的方式! 最後不惜千里迢迢從高雄北上,選擇了在林口長庚醫院手術,內心由衷感謝醫師專業的判斷和精湛的醫術,及術後護理師們的親切細心照顧,將永遠銘記在心。 這一路走來,雖然經歷了人生中的大考驗,但我也挺過來了。如今術後剛好滿一年,我不後悔當初的決定,現在的我生活不受影響,我還是充滿快樂自信的迎接每一天! 小瑩的故事 某天,還在餵母乳的期間中,發現了自己左胸有硬塊,但一直認為只是乳腺塞住了而已,就一直沒去理會。但時間久了,開始覺得不對勁,就先把母乳停了,然後到家裡附近的醫院檢查,醫生也說只是乳腺塞住沒那麼快退,所以我就又不管它了。在老公的催促下,到台北長庚做第二次檢查,醫生照了超音波後就跟我說要切片,天真的我心裡還想只是乳腺塞住而已,沒想到一個禮拜看報告後,讓我腦中一片空白,乳癌一期!很快的我決定了抗癌計劃:全切、重建! 沒想到手術完畢,從原本的一期變三期淋巴轉移,我心中真是一直在想:我才34歲,怎麼會得癌症呢?一直不願意相信,而且還三期了,我心愛的老公還有兩個孩子怎麼辦呢?心中的想法一直很負面,覺得我的人生很可悲。 但我很感謝我的家人、朋友,還有治療我的醫生、護理師,讓我可以勇敢的面對。也很感謝乳房重建協 會的無私奉獻,幫助許多乳癌婦女,讓我們可以重獲自信。感動的心無法言語,真的謝謝你們,也祝福你們事事順心幸福美滿! 小悠的故事 2018年6月罹癌,一開始知道的時候完全不能接受,尤其醫生告知我乳房可能要切除,我的眼淚用噴的,覺得自己胸部夠小了還要切除,後面醫生告知我如果病情不嚴重可直接切除後重建,我當下就覺得不管多少錢我一定要做,滿足自己本來就想隆乳的心情,所以我在2019年2月重建好我的胸部,做完當下真的覺得太不可思議,本來我只有A罩杯吧,手術完馬上升級兩個罩杯,以前不敢不能穿的衣服我現在都能穿了,而且我也比之前有自信多了,在性方面也是,走路都能抬頭挺胸,真的很感謝我的醫生郭玟伶,還有幫我重建的鄭明輝醫生。 我的胸部形狀很自然也很漂亮我很滿意,這麼瘦的我也能幫我做到我想要的尺吋,重建完後我都忘了自己是病人,男朋友和我都很滿意,夏天能穿以前從不敢穿的比基尼,所以生病了也是能活的很快樂,大家千萬別因為別人說都生病還管隆胸部這種話,自己喜歡就好,乳房重建完的這兩年我現在偶爾才會按摩,但胸部還是很軟Q!真心建議年輕癌友一定要重建,決對不會後悔。 重建完連工作機會也變多,真的很謝謝我的醫生鄭明輝,還有個案管理師林怡伶細心的跟我解釋重建過程,讓我不會那麼害怕並增長知識。 小宜的故事 我在2016年5月醫生宣布確診罹患左乳乳癌二期的當下,心裡想者「為什麼是我?」之後伴隨著我的是數不盡的哭泣,看了好幾位醫師都說因爲是多發性,所以必須全切,後來漸漸地接受自己罹癌的事實,覺得活命最重要,要全切就全切吧! 乳房全切術前,在各種乳癌書籍及網路上收集了許多資訊,包含乳癌的手術治療、化學治療、放射線治療、乳房重建….等等;我在網路上搜到台灣乳房重建協會,得知林口長庚醫院有個專業的乳房重建中心,協會網站上提供了很多重建的知識及資訊,讓我對於乳房重建有一些基本的認識,於是我有了重建的想法,使用DIEP深下腹動脈穿通枝皮瓣的方式,不犧牲橫腹直肌,並且可兼縮小腹部的效果。 當時心中屬意林口長庚醫院的鄭明輝醫師,但因為乳癌的治療是在別家醫院,而我又比較傾向乳房切除後立即性重建,只要挨一次刀就好了,所以只好放棄選擇在同一家醫院做立即性重建。乳房切除術後恢復意識時,只覺得左乳全切的部位好痛好痛,可是為何肚子沒什麽感覺,手下意識地往肚子上摸,我蹦出了一句「為什麽肚子沒動刀?」恢復室裡的護理師沒有跟我多說什麽,回病房時已是深夜。直到隔天早上主治醫師來巡房,家人才告知我實情,醫師也親自說明術中前哨淋巴化驗感染兩顆,並做腋下淋巴廓清術,醫師考量到未來我可能要做放療‚避免傷害到重建組織,原本要做自體重建改成裝组織擴張器,等全部治療完畢,再二次手術重建。 想到要再多挨一次刀當下有點晴天霹靂,但覺得也許這是天意,老天爺給我再一次重新選擇的機會,於是我選擇了林口長庚醫院進行延遲性重建。術後治療計劃只有化療沒有放療,歷經8次化療·,2017年2月開始吃泰莫西芬,同年至鄭明輝醫師的門診諮詢;後因個人因素直到2018年7月才動刀重建,也因此組織擴張器在我身體裡「住」了2年多,皮膚與胸大肌合而為一,鄭醫師打算將皮瓣組織放置於皮底下,為了兩側乳房對稱右乳將進行縮乳,我很放心地將自己交付予鄭醫師及所屬的醫療團隊。 重建手術的前一晚心情很緊張地撥電話給林怡伶個管師,她傾聽我的不安,再次解說隔日動刀的流程並安撫我緊張的情緒,非常地親切專業,且深具耐心!隔日手術非常成功。術後轉進5B顯微重建加護病房,因為需要臥床一段時間,全身動彈不得過程中有些辛苦,但是護理師們除了固定時間給藥、量測體溫、血壓.…等等例行工作之外,早上還會協助妳刷牙、擦臉;定時幫妳翻身拍背還有幫妳擦澡,把病患照顧得無微不至,真的辛苦護理師們了!主刀的鄭明輝醫師每天早上都來巡房講解術後狀況,看傷口復原進度並重視病患飲食,強調「一肉、二魚、三蛋、四奶、五蔬果」促進傷口癒合。而隨行的徐邦瀚醫師、鄭美隨專科護理師(美隨姐),也是每天關心我的復原狀況,後來轉到5A普通病房,護理師們依舊親切、專業有耐心地照顧著我,醫師們仍然每天巡房直到我出院。 重建之後我的左乳不再因為組織擴張器而覺得卡卡痛痛的,左、右乳形狀自然匀稱觸感柔軟,穿著外表上就如同過去未罹癌前一樣,我可以有自信勇敢地走向裸身的泡湯人群裡,真的很感謝鄭明輝醫師及其醫療團隊,從術前的門診諮詢(詳細解說並給予專業建議)檢查,術中鄭醫師花費心力幫我把皮膚與胸大肌分離,右乳縮乳並將左乳皮瓣塑形重建,形狀對稱自然。住院期醫療團隊視病猶親地照顧著我到術後的回診追蹤,這一段「重建之路」因為鄭明輝醫師的妙手回春,因為醫療團隊的專業照護,雖然術後住院臥床過程有點辛苦卻也值得。 我真心認為當初選擇鄭明輝醫師及其醫療團隊是選對了,最後感謝台灣乳房重建協會,為乳癌婦女重建信心也提供重建補助款,讓我可以藉此機會對於曾經照顧過我的醫療團隊,表達最由衷的感謝。 回到乳房重建中心

